HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SUPPEC SASDATA 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 Supplemental Qualifiers for EC HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001000000000000000000000 STUDYID Study Identifier RDOMAIN Related Domain Abbreviation USUBJID Unique Subject Identifier IDVAR Identifying Variable IDVARVALIdentifying Variable Value %QNAM Qualifier Variable Name &%QLABEL Qualifier Variable Label -^QVAL Data Value R QORIG Origin ° QEVAL Evaluator ¸ HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001ECC4591001 1005 10051317ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051317ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051317ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051317ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051317ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051317ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051328ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051328ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051328ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051328ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051328ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051328ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051339ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051339ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051339ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051339ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051410ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051410ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051410ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051410ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051412ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051412ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051412ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051412ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051412ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051412ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051413ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051413ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051413ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051413ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051413ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051413ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051414ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051414ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051415ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051415ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051415ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051415ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051417ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051417ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051417ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051417ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051418ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051418ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051418ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051418ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051418ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051418ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051419ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051419ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051419ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051419ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051420ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051420ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051420ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051420ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051420ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051420ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051421ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051421ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051421ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051421ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051422ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051422ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051422ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051422ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051424ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051424ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051424ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051424ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051424ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051424ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051425ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051425ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051425ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051425ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051425ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051425ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051427ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051427ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051427ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051427ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051429ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051429ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051429ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051429ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051429ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051429ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051430ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051430ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051430ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051430ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051431ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051431ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051431ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051431ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051431ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051431ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051436ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051436ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051436ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051436ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051436ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051436ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051437ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051437ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051437ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051437ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051438ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051438ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051438ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051438ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051439ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051439ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051439ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051439ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051439ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051439ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051440ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051440ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051440ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051440ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051441ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051441ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051441ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051441ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051441ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051441ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051444ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051444ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051444ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051444ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051445ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051445ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051445ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051445ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051447ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051447ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051447ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051447ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051447ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051447ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051448ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051448ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051448ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051448ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051449ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051449ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051449ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051449ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051449ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051449ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051450ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051450ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051450ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051450ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051451ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051451ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051451ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051451ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051451ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051451ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061183ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061183ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061183ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061183ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061184ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061184ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061184ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061184ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061184ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061184ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061188ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061188ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061188ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061188ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061189ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061189ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061189ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061189ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061189ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061189ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061190ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061190ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061190ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061190ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061190ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061190ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061191ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061191ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061191ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061191ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061191ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061191ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061196ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061196ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061196ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061196ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061200ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061200ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061200ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061200ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061201ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061201ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061201ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061201ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061201ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061201ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061203ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061203ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061203ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061203ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061203ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061203ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061206ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061206ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061206ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061206ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061206ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061206ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061207ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061207ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061207ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061207ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061207ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061207ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061209ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061209ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061209ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061209ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061209ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061209ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061212ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061212ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061212ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061212ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061213ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061213ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061213ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061213ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061213ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061213ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061214ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061214ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061214ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061214ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061219ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061219ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061219ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061219ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061220ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061220ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061220ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061220ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061220ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061220ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061221ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061221ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061221ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061221ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061221ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061221ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061223ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061223ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061223ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061223ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061224ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061224ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061224ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061224ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061224ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061224ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061226ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061226ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061226ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061226ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061227ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061227ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061227ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061227ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061227ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061227ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061228ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061228ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061228ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061228ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061229ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061229ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061229ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061229ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061230ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061230ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061230ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061230ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061230ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061230ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061231ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061231ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061231ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061231ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061231ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061231ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061232ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061232ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061232ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061232ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061233ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061233ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061233ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061233ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061234ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061234ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061234ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061234ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061234ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061234ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061235ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061235ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061235ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061235ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061236ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061236ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061236ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061236ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061236ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061236ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061237ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061237ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061237ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061237ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061239ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061239ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061239ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061239ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061241ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061241ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061241ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061241ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061241ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061241ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061242ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061242ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061242ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061242ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061242ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061242ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061243ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061243ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061243ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061243ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061243ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061243ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061244ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061244ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061244ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061244ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061244ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061244ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061245ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061245ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061245ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061245ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061247ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061247ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061247ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061247ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061248ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061248ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061248ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061248ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061249ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061249ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061249ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061249ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061249ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061249ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061250ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061250ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061252ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061252ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061252ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061252ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061252ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061252ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061253ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061253ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061254ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061254ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061254ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061254ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061254ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061254ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061256ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061256ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061256ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061256ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061256ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061256ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061257ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061257ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061257ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061257ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061258ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061258ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061258ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061258ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061258ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061258ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061259ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061259ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061259ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061259ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061260ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061260ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061260ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061260ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061261ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061261ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061261ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061261ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061261ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061261ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061262ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061262ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061262ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061262ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061264ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061264ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061264ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061264ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061264ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061264ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061265ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061265ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061265ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1006 10061265ECSEQ1FDDTC Date of First Delay 2020-12-15 CRF C4591001ECC4591001 1006 10061265ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061265ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061265ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061266ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061266ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061266ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061266ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061267ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061267ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061267ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061267ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061269ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061269ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061269ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061269ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061269ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061269ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061270ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061270ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061271ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061271ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061271ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061271ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061271ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061271ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061272ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061272ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061272ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061272ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061272ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061272ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061273ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061273ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061276ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061276ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061276ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061276ECSEQ4ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1006 10061276ECSEQ4FDDTC Date of First Delay 2021-06-08 CRF C4591001ECC4591001 1006 10061277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061277ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061277ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061277ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061277ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061279ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061279ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061279ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061283ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061283ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061284ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061284ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061285ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061285ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061287ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061287ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061290ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061291ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061291ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061292ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061293ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061293ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061293ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061293ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061293ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061293ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061294ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061294ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061295ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061295ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061298ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061298ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071409ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071409ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071409ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071409ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071409ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071409ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071414ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071414ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071415ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071415ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071415ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071415ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071415ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071415ECSEQ2ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1007 10071415ECSEQ2FDDTC Date of First Delay 2020-11-12 CRF C4591001ECC4591001 1007 10071417ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071417ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071417ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071417ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071417ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071417ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071429ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071429ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071429ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071429ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071429ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071429ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071467ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071467ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071467ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071467ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071467ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071467ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071469ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071469ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071469ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071469ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071469ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071469ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071471ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071471ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071471ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071471ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071471ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071471ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071472ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071472ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071472ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071472ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071475ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071475ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071475ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071475ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071475ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071475ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071476ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071476ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071476ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071476ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071476ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071476ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071478ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071478ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071478ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071478ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071480ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071480ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071480ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071480ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071481ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071481ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071481ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071481ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071482ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071482ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071482ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071482ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071482ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071482ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071483ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071483ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071483ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071483ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071484ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071484ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071484ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071484ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071485ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071485ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071485ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071485ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071485ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071485ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071488ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071488ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071488ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071488ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071488ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071488ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071490ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071490ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071490ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071490ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071490ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071490ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071492ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071492ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071492ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071492ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071492ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071492ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071494ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071494ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071494ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071494ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071494ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071494ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071495ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071495ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071495ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071495ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071496ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071496ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071496ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071496ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071497ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071497ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071497ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071497ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071497ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071497ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071499ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071499ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071499ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071499ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071499ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071499ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071500ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071500ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071500ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071500ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071500ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071500ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071504ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071504ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071504ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071504ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071504ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071504ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071505ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071505ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071505ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071505ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071506ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071506ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071506ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071506ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071506ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071506ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071507ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071507ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071507ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071507ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071508ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071508ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071508ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071508ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071508ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071508ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071509ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071509ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071509ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071509ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071511ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071511ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071511ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071511ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071512ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071512ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071512ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071512ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071512ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071512ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071514ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071514ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071514ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071514ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071514ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071514ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071515ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071515ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071515ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071515ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071515ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071515ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071516ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071516ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071516ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071516ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071517ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071517ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071517ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071517ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071517ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071517ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071518ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071518ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071518ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071518ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071518ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071518ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071519ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071519ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071519ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071519ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071520ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071520ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071520ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071520ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071521ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071521ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071521ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071521ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071521ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071521ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071522ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071522ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071522ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071522ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071523ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071523ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071523ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071523ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071523ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071523ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071524ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071524ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071524ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071524ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071525ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071525ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071525ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071525ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071525ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071525ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071526ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071526ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071526ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071526ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071526ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071526ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071527ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071527ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071527ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071527ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071528ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071528ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071528ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071528ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071528ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071528ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071529ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071529ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071529ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071529ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071529ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071529ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071530ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071530ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071530ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071530ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071530ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071530ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071531ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071531ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071531ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071531ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071533ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071533ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071533ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071533ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071535ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071535ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071535ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071535ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071535ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071535ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071536ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071536ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071536ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071536ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071536ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071536ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071537ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071537ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071537ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071537ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071537ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071537ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071539ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071539ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071539ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071539ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071540ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071540ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071540ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071540ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071541ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071541ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071541ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071541ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071542ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071542ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071542ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071542ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071542ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071542ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071543ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071543ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071543ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071543ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071543ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071543ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071544ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071544ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071544ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071544ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071544ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071544ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071546ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071546ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071546ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071546ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071546ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071546ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071547ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071547ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071547ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071547ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071550ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071550ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071550ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071550ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071550ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071550ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071551ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071551ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071551ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071551ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071552ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071552ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071552ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071552ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071554ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071554ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071554ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071554ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071554ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071554ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071555ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071555ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071555ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071555ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071555ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071555ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071557ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071557ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071557ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071557ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071557ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071557ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071558ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071558ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071558ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071558ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071558ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071558ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071559ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071559ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071559ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071559ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071560ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071560ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071560ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071560ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071561ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071561ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071561ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071561ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071561ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071561ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071562ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071562ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071562ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071562ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071563ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071563ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071563ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071563ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071564ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071564ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071564ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071564ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071564ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071564ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071565ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071565ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071565ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071565ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071565ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071565ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071566ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071566ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071566ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071566ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071566ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071566ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071567ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071567ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071567ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071567ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071567ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071567ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071568ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071568ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071568ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071568ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071569ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071569ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071569ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071569ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071570ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071570ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071570ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071570ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071571ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071571ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071571ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071571ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071571ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071571ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071572ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071572ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071572ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071572ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071572ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071572ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071573ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071573ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071573ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071573ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071573ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071573ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071574ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071574ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071574ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071574ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071574ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071574ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071575ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071575ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071575ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071575ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071575ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071575ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071576ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071576ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071576ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071576ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071577ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071577ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071577ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071577ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071578ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071578ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071578ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071578ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071579ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071579ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071579ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071579ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071579ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071579ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071580ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071580ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071580ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071580ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071580ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071580ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071581ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071581ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071581ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071581ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071582ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071582ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071582ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071582ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071582ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071582ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071583ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071583ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071583ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071583ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071584ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071584ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071584ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071584ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071584ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071584ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071585ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071585ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071585ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071585ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071586ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071586ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071586ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071586ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071587ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071587ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071587ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071587ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071587ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071587ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071588ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071588ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071588ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071588ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071588ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071588ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071589ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071589ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071589ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071589ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071590ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071590ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071590ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071590ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071590ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071590ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071591ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071591ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071591ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071591ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071592ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071592ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071592ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071592ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071592ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071592ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071593ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071593ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071593ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071593ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071593ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071594ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071594ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071594ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071594ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071594ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071594ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071595ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071595ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071595ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071595ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071596ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071596ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071596ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071596ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071597ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071597ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071597ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071597ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071597ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071597ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071599ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071599ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071599ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071599ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071599ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071599ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071600ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071600ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071600ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071600ECSEQ4ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1007 10071600ECSEQ4FDDTC Date of First Delay 2021-06-22 CRF C4591001ECC4591001 1007 10071601ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071601ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071601ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071601ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071601ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071601ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071602ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071602ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071602ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071602ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071602ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071602ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071603ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071603ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071603ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071603ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071603ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071603ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071604ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071604ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071604ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071604ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071604ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071604ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071605ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071605ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071605ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071605ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071605ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071605ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071606ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071606ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071606ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071606ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071606ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071606ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071607ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071607ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071607ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071607ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071608ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071608ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071608ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071608ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071609ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071609ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071609ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071609ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071609ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071609ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071610ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071610ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071610ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071610ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071610ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071610ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071612ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071612ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071612ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071612ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071612ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071612ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071613ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071613ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071613ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071613ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071614ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071614ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071614ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071614ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071615ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071615ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071615ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071615ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071615ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071615ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071616ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071616ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071616ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071616ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071616ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071616ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071617ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071617ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071617ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071617ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071618ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071618ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071618ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071618ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071618ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071618ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071619ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071619ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071619ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071619ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071619ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071619ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071620ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071620ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071620ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071620ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071620ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071620ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071621ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071621ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071621ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071621ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071621ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071621ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071622ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071622ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071622ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071622ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071622ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071623ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071623ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071623ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071623ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071624ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071624ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071624ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071624ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071625ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071625ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071625ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071625ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071626ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071626ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071626ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071626ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071626ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071626ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071627ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071627ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071627ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071627ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071627ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071627ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071628ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071628ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071628ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071628ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071628ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071628ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071629ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071629ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071629ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071629ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071630ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071630ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071630ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071630ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071631ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071631ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071631ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071631ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071631ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071631ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071632ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071632ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071632ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071632ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071633ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071633ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071633ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071633ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071633ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071633ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071634ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071634ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071634ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071634ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071634ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071634ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071635ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071635ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071635ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071635ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071635ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071635ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071636ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071636ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071636ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071636ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071636ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071636ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071638ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071638ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071638ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071638ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071638ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071638ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071639ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071639ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071639ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071639ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071639ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071639ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071640ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071640ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071640ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071640ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071641ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071641ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071641ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071641ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071641ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071641ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071642ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071642ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071642ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071642ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071642ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071642ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071643ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071643ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071643ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071643ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071643ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071643ECSEQ3ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1007 10071643ECSEQ3FDDTC Date of First Delay 2021-05-17 CRF C4591001ECC4591001 1007 10071643ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071643ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071644ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071644ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071644ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071644ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071644ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071644ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071645ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071645ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071645ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071645ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071646ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071646ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071646ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071646ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071647ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071647ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071647ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071647ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071647ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071647ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071648ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071648ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071648ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071648ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071649ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071649ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071649ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071649ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071649ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071649ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071650ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071650ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071650ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071650ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071651ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071651ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071651ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071651ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071651ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071651ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071652ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071652ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071652ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071652ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071653ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071653ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071653ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071653ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071653ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071653ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071654ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071654ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071654ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071654ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071654ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071654ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071655ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071655ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071655ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071655ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071656ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071656ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071656ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071656ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071656ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071656ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071658ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071658ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071658ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071658ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071659ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071659ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071659ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071659ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071659ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071659ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071660ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071660ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071660ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071660ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071661ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071661ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071661ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071661ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071661ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071661ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071662ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071662ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071662ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071662ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071662ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071662ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081751ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081751ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081751ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081751ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081752ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081752ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081752ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081752ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081753ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081753ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081753ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081753ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081753ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081753ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081754ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081754ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081754ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081754ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081754ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081754ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081755ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081755ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081755ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081755ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081755ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081755ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081756ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081756ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081756ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081756ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081757ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081757ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081757ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081757ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081758ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081758ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081758ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081758ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081758ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081758ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081760ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081760ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081760ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081760ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081760ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081760ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081761ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081761ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081761ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081761ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081763ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081763ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081763ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081763ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081764ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081764ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081764ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081764ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081764ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081764ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081767ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081767ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081767ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081767ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081768ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081768ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081768ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081768ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081768ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081768ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081769ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081769ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081769ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081769ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081769ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081769ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081770ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081770ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081770ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081770ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081770ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081770ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081771ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081771ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081771ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081771ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081771ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081771ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081773ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081773ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081773ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081773ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081774ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081774ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081774ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081774ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081774ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081774ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081775ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081775ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081775ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081775ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081777ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081777ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081777ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081777ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081777ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081777ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081780ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081780ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081780ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081780ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081781ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081781ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081781ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081781ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081785ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081785ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081785ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081785ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081785ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081785ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081788ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081788ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081788ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081788ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081789ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081789ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081789ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081789ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081789ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081789ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081790ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081790ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081790ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081790ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081791ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081791ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081791ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081791ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081791ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081791ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081792ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081792ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081792ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081792ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081792ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081792ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081793ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081793ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081793ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081793ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081794ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081794ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081794ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081794ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081795ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081795ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081795ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081795ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081795ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081795ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081796ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081796ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081796ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081796ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081797ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081797ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081797ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081797ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081797ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081797ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081798ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081798ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081798ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081798ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081799ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081799ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081799ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081799ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081799ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081799ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081800ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081800ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081800ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081800ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081800ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081800ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081801ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081801ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081801ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081801ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081802ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081802ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081802ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081802ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081802ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081802ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081803ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081803ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081803ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081803ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081804ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081804ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081804ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081804ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081805ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081805ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081805ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081805ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081805ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081805ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081806ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081806ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081806ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081806ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081806ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081806ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081807ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081807ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081807ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081807ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081808ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081808ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081808ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081808ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081809ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081809ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081809ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081809ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081810ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081810ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081810ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081810ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081810ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081810ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081811ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081811ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081811ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081811ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081811ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081811ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081812ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081812ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081812ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081812ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081813ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081813ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081813ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081813ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081813ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081813ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081814ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081814ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081814ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081814ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081814ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081814ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081815ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081815ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081815ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081815ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081816ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081816ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081816ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081816ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081816ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081816ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081817ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081817ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081817ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081817ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081818ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081818ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081818ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081818ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081818ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081818ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081819ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081819ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081819ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081819ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081820ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081820ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081820ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081820ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081821ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081821ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081821ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081821ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081821ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081821ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081822ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081822ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081822ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081822ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081823ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081823ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081823ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081823ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081823ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081823ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081824ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081824ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081824ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081824ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081824ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081824ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081824ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081824ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081824ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081824ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081825ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081825ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081825ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081825ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081825ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081825ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081825ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081825ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081825ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081825ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081825ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081825ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081825ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081826ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081826ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081826ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081826ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081826ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081826ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081826ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081826ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081826ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081826ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081827ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081827ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081827ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081827ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081827ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081827ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081827ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081827ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081827ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081827ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081828ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081828ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081828ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081828ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081828ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081828ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081828ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081828ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081828ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081828ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081828ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081828ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081828ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081829ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081829ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081829ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081829ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081829ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081829ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081829ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081829ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081829ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081829ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081830ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081830ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081830ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081830ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081830ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081830ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081830ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081830ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081830ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081830ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081830ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081830ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081830ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081831ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081831ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081831ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081831ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081831ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081831ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081831ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081831ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081831ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081831ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081832ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081832ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081832ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081832ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081832ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081832ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081832ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081832ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081832ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081832ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081833ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081833ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081833ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081833ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081833ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081833ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081833ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081833ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081833ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081833ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081833ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081833ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081833ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081834ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081834ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081834ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081834ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081834ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081834ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081834ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081834ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081834ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081834ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081835ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081835ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081835ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081835ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081835ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081835ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081835ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081835ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081835ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081835ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081836ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081836ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081836ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081836ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081836ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081836ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081836ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081836ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081836ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081836ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081836ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081836ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081836ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081837ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081837ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081837ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081837ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081837ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081837ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081837ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081837ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081837ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081837ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081837ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081837ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081837ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081838ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081838ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081838ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081838ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081838ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081838ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081838ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081838ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081838ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081838ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081839ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081839ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081839ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081839ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081839ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081839ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081839ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081839ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081839ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081839ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081840ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081840ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081840ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081840ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081840ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081840ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081840ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081840ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081840ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081840ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081840ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081840ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081840ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081841ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081841ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081841ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081841ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081841ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081841ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081841ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081841ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081841ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081841ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081842ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081842ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081842ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081842ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081842ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081842ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081842ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081842ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081842ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081842ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081842ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081842ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081842ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081843ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081843ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081843ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081843ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081843ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081843ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081843ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081843ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081843ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081843ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081844ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081844ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081844ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081844ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081844ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081844ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081844ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081844ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081844ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081844ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081844ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081844ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081844ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081845ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081845ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081845ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081845ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081845ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081845ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081845ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081845ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081845ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081845ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081845ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081845ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081845ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081846ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081846ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081846ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081846ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081846ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081846ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081846ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081846ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081846ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081846ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081847ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081847ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081847ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081847ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081847ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081847ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081847ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081847ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081847ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081847ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081848ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081848ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081848ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081848ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081848ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081848ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081848ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081848ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081848ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081848ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081849ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081849ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081849ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081849ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081849ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081849ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081849ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081849ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081849ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081849ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081849ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081849ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081849ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081850ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081850ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081850ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081850ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081850ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081850ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081850ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081850ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081850ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081850ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081851ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081851ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081851ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081851ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081851ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081851ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081851ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081851ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081851ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081851ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081851ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081851ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081851ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081852ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081852ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081852ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081852ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081852ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081852ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081852ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081852ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081852ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081852ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081852ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081852ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081852ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081853ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081853ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081853ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081853ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081853ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081853ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081853ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081853ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081853ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081853ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081853ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081853ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081853ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081854ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081854ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081854ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081854ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081854ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081854ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081854ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081854ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081854ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081854ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081855ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081855ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081855ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081855ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081855ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081855ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081855ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081855ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081855ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081855ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081856ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081856ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081856ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081856ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081856ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081856ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081856ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081856ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081856ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081856ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081856ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081856ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081856ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081857ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081857ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081857ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081857ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081857ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081857ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081857ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081857ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081857ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081857ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081858ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081858ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081858ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081858ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081858ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081858ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081858ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081858ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081858ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081858ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081858ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081858ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081858ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081859ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081859ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081859ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081859ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081859ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081859ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081859ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081859ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081859ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081859ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081860ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081860ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081860ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081860ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081860ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081860ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081860ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081860ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081860ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081860ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081861ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081861ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081861ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081861ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081861ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081861ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081861ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081861ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081861ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081861ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081861ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081861ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081861ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081862ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081862ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081862ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081862ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081862ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081862ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081862ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081862ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081862ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081862ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081863ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081863ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081863ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081863ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081863ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081863ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081863ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081863ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081863ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081863ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081863ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081863ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081863ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081864ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081864ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081864ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081864ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081864ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081864ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081864ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081864ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081864ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081864ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081865ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081865ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081865ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081865ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081865ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081865ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081865ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081865ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081865ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081865ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081866ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081866ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081866ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081866ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081866ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081866ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081866ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081866ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081866ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081866ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081866ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081866ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081866ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081867ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081867ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081867ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081867ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081867ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081867ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081867ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081867ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081867ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081867ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081867ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081867ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081867ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081868ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081868ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081868ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081868ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081868ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081868ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081868ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081868ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081868ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081868ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081869ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081869ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081869ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081869ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081869ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081869ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081869ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081869ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081869ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081869ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081869ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081869ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081869ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081870ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081870ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081870ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081870ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081870ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081870ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081870ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081870ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081870ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081870ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081871ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081871ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081871ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081871ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081871ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081871ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081871ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081871ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081871ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081871ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081871ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081871ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081871ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081871ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081871ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081872ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081872ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081872ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081872ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081872ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081872ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081872ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081872ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081872ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081872ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081872ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081872ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081872ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081873ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081873ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081873ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081873ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081873ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081873ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081873ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081873ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081873ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081873ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081874ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081874ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081874ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081874ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081874ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081874ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081874ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081874ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081874ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081874ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081875ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081875ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081875ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081875ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081875ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081875ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081875ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081875ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081875ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081875ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081875ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081875ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081875ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081876ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081876ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081876ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081876ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081876ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081876ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081876ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081876ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081876ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081876ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081877ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081877ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081877ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081877ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081877ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081877ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081877ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081877ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081877ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081877ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081877ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081877ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081877ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081878ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081878ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081878ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081878ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081878ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081878ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081878ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081878ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081878ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081878ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081879ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081879ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081879ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081879ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081879ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081879ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081879ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081879ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081879ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081879ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081880ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081880ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081880ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081880ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081880ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081880ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081880ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081880ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081880ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081880ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081880ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081880ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081880ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081881ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081881ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081881ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081881ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081881ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081881ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081881ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081881ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081881ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081881ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081881ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081881ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081881ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081882ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081882ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081882ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081882ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081882ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081882ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081882ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081882ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081882ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081882ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081883ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081883ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081883ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081883ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081883ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081883ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081883ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081883ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081883ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081883ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081884ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081884ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081884ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081884ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081884ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081884ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081884ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081884ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081884ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081884ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081884ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081884ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081884ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081884ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081884ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081885ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081885ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081885ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081885ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081885ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081885ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081885ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081885ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081885ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081885ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081886ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081886ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081886ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081886ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081886ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081886ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081886ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081886ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081886ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081886ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081887ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081887ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081887ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081887ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081887ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081887ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081887ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081887ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081887ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081887ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081887ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081887ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081887ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081888ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081888ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081888ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081888ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081888ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081888ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081888ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081888ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081888ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081888ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081888ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081888ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081888ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081889ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081889ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081889ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081889ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081889ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081889ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081889ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081889ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081889ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081889ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081890ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081890ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081890ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081890ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081890ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081890ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081890ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081890ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081890ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081890ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081891ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081891ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081891ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081891ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081891ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081891ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081891ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081891ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081891ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081891ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081891ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081891ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081891ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081892ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081892ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081892ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081892ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081892ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081892ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081892ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081892ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081892ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081892ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081892ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081892ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081892ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081893ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081893ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081893ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081893ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081893ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081893ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081893ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081893ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081893ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081893ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081894ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081894ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081894ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081894ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081894ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081894ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081894ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081894ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081894ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081894ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081895ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081895ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081895ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081895ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081895ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081895ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081895ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081895ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081895ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081895ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081896ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081896ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081896ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081896ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081896ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081896ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081896ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081896ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081896ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081896ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081896ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081896ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081896ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081897ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081897ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081897ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081897ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081897ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081897ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081897ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081897ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081897ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081897ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081898ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081898ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081898ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081898ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081898ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081898ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081898ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081898ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081898ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081898ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081898ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081898ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081898ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081899ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081899ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081899ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081899ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081899ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081899ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081899ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081899ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081899ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081899ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081899ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081899ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081899ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081900ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081900ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081900ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081900ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081900ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081900ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081900ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081900ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081900ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081900ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081901ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081901ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081901ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081901ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081901ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081901ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081901ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081901ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081901ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081901ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081901ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081901ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081901ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081902ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081902ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081902ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081902ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081902ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081902ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081902ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081902ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081902ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081902ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081902ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081902ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081902ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081903ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081903ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081903ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081903ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081903ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081903ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081903ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081903ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081903ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081903ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081904ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081904ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081904ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081904ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081904ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081904ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081904ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081904ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081904ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081904ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081904ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081904ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081904ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081905ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081905ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081905ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081905ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081905ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081905ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081905ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081905ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081905ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081905ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081906ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081906ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081906ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081906ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081906ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081906ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081906ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081906ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081906ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081906ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081907ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081907ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081907ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081907ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081907ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081907ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081907ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081907ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081907ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081907ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081907ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081907ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081907ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081908ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081908ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081908ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081908ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081908ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081908ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081908ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081908ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081908ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081908ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081909ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081909ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081909ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081909ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081909ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081909ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081909ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081909ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081909ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081909ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081909ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081909ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081909ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081910ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081910ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081910ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081910ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081910ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081910ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081910ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081910ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081910ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081910ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081911ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081911ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081911ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081911ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081911ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081911ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081911ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081911ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081911ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081911ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081911ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081911ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081911ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081912ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081912ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081912ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081912ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081912ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081912ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081912ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081912ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081912ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081912ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081913ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081913ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081913ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081913ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081913ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081913ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081913ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081913ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081913ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081913ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081913ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081913ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081913ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081914ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081914ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081914ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081914ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081914ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081914ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081914ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081914ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081914ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081914ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081914ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081914ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081914ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081915ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081915ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081915ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081915ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081915ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081915ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081915ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081915ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081915ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081915ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081916ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081916ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081916ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081916ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081916ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081916ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081916ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081916ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081916ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081916ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081917ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081917ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081917ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081917ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081917ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081917ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081917ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081917ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081917ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081917ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081917ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081917ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081917ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081918ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081918ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081918ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081918ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081918ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081918ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081918ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081918ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081918ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081918ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081919ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081919ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081919ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081919ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081919ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081919ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081919ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081919ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081919ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081919ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081919ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081919ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081919ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081920ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081920ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081920ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081920ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081920ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081920ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081920ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081920ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081920ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081920ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081921ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081921ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081921ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081921ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081921ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081921ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081921ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081921ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081921ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081921ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081921ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081921ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081921ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081922ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081922ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081922ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081922ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081922ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081922ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081922ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081922ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081922ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081922ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081923ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081923ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081923ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081923ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081923ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081923ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081923ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081923ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081923ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081923ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081923ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081923ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081923ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081924ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081924ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081924ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081924ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081924ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081924ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081924ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081924ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081924ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081924ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081924ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081924ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081924ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081925ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081925ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081925ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081925ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081925ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081925ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081925ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081925ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081925ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081925ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081926ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081926ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081926ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081926ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081926ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081926ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081926ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081926ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081926ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081926ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081926ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081926ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081926ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081927ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081927ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081927ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081927ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081927ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081927ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081927ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081927ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081927ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081927ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081928ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081928ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081928ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081928ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081928ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081928ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081928ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081928ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081928ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081928ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081929ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081929ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081929ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081929ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081929ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081929ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081929ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081929ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081929ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081929ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081930ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081930ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081930ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081930ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081930ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081930ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081930ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081930ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081930ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081930ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081930ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081930ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081930ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081931ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081931ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081931ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081931ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081931ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081931ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081931ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081931ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081931ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081931ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081931ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081931ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081931ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081932ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081932ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081932ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081932ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081932ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081932ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081932ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081932ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081932ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081932ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081932ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081932ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081932ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081933ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081933ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081933ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081933ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081933ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081933ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081933ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081933ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081933ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081933ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081933ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081933ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081933ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081934ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081934ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081934ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081934ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081934ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081934ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081934ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081934ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081934ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081934ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081935ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081935ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081935ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081935ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081935ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081935ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081935ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081935ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081935ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081935ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081936ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081936ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081936ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081936ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081936ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081936ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081936ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081936ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081936ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081936ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081936ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081936ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081936ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081937ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081937ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081937ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081937ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081937ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081937ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081937ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081937ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081937ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081937ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081938ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081938ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081938ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081938ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081938ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081938ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081938ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081938ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081938ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081938ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081938ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081938ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081938ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081940ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081940ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081940ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081940ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081940ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081940ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081940ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081940ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081940ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081940ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081941ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081941ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081941ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081941ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081941ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081941ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081941ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081941ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081941ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081941ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081941ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081941ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081941ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081942ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081942ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081942ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081942ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081942ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081942ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081942ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081942ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081942ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081942ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081942ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081942ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081942ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081943ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081943ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081943ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081943ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081943ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081943ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081943ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081943ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081943ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081943ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091204ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091204ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091204ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091204ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091204ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091204ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091204ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091204ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091204ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091204ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091204ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091204ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091204ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091205ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091205ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091205ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091205ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091205ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091205ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091205ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091205ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091205ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091205ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091208ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091208ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091208ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091208ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091208ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091208ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091208ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091208ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091208ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091208ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091208ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091208ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091208ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091209ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091209ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091209ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091209ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091209ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091209ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091209ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091209ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091209ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091209ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091212ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091212ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091212ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091212ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091212ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091212ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091212ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091212ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091212ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091212ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091212ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091212ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091212ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091213ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091213ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091213ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091213ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091213ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091213ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091213ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091213ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091213ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091213ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091213ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091213ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091213ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091216ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091216ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091216ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091216ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091216ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091216ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091216ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091216ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091216ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091216ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091218ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091218ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091218ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091218ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091218ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091218ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091218ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091218ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091218ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091218ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091220ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091220ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091220ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091220ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091220ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091220ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091220ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091220ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091220ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091220ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091221ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091221ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091221ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091221ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091221ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091221ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091221ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091221ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091221ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091221ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091223ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091223ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091223ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091223ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091223ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091223ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091223ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091223ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091223ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091223ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091226ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091226ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091226ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091226ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091226ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091226ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091226ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091226ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091226ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091226ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091226ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091226ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091226ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091227ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091227ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091227ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091227ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091227ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091227ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091227ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091227ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091227ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091227ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091229ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091229ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091229ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091229ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091229ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091229ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091229ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091229ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091229ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091229ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091229ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091229ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091229ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091231ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091231ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091231ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091231ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091231ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091231ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091231ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091231ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091231ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091231ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091233ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091233ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091233ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091233ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091233ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091233ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091233ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091233ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091233ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091233ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091233ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091233ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091233ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091234ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091234ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091234ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091234ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091234ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091234ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091234ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091234ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091234ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091234ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091237ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091237ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091237ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091237ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091237ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091237ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091237ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091237ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091237ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091237ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091238ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091238ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091238ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091238ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091238ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091238ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091238ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091238ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091238ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091238ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091238ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091238ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091238ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091240ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091240ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091240ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091240ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091240ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091240ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091240ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091240ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091240ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091240ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091246ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091246ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091246ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091246ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091246ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091246ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091246ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091246ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091246ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091246ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091246ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091246ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091246ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091247ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091247ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091247ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091247ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091247ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091247ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091247ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091247ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091247ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091247ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091249ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091249ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091249ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091249ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091249ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091249ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091249ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091249ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091249ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091249ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091249ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091249ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091249ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091265ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091265ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091265ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091265ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091265ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091265ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091265ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091265ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091265ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091265ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091266ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091266ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091266ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091266ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091266ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091266ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091266ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091266ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091266ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091266ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091266ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091266ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091266ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091267ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091267ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091267ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091267ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091267ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091267ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091267ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091267ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091267ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091267ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091267ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091267ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091267ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091269ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091269ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091269ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091269ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091269ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091269ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091269ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091269ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091269ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091269ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091272ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091272ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091272ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091272ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091272ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091272ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091272ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091272ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091272ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091272ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091273ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091273ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091273ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091273ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091273ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091273ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091273ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091274ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091274ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091274ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091274ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091274ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091274ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091274ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091275ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091275ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091275ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091275ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091275ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091275ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091275ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091277ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091277ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091277ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091277ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091277ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091277ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091277ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091281ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091281ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091281ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091281ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091281ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091281ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091281ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091281ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091281ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091281ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091282ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091282ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091282ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091282ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091282ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091282ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091282ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091283ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091283ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091283ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091283ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091283ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091283ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091283ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091287ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091287ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091287ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091292ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091292ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091292ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091292ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091293ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091293ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091293ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091293ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091293ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091293ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091293ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091293ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091293ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091293ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091293ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091293ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091293ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091294ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091294ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091294ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091294ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091294ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091294ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091294ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091296ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091296ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091296ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091296ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091296ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091296ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091296ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091301ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091301ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091301ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091301ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091301ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091301ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091301ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091301ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091301ECSEQ3ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1009 10091301ECSEQ3FDDTC Date of First Delay 2021-05-04 CRF C4591001ECC4591001 1009 10091301ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091301ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091301ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091301ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091303ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091303ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091303ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091303ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091303ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091303ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091303ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091303ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091303ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091303ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091303ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091303ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091303ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091304ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091304ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091304ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091304ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091304ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091304ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091304ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091304ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091304ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091304ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091305ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091305ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091305ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091305ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091305ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091305ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091305ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091305ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091305ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091305ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091305ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091305ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091305ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091306ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091306ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091306ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091306ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091306ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091306ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091306ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091306ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091306ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091306ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091306ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091306ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091306ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091307ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091307ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091307ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091307ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091307ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091307ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091307ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091307ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091307ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091307ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091308ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091308ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091308ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091308ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091308ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091308ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091308ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091308ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091308ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091308ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091309ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091309ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091309ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091309ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091309ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091309ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091309ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091309ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091309ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091309ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091310ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091310ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091310ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091310ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091310ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091310ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091310ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091310ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091310ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091310ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091311ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091311ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091311ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091311ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091311ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091311ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091311ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091311ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091311ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091311ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091311ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091311ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091311ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091312ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091312ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091312ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091312ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091312ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091312ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091312ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091312ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091312ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091312ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091312ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091312ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091312ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091313ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091313ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091313ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091313ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091313ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091313ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091313ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091313ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091313ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091313ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091314ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091314ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091314ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091314ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091314ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091314ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091314ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091314ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091314ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091314ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091314ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091314ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091314ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091315ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091315ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091315ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091315ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091315ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091315ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091315ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091315ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091315ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091315ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091316ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091316ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091316ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091316ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091316ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091316ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091316ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091316ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091316ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091316ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091316ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091316ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091316ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091317ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091317ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091317ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091317ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091317ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091317ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091317ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091317ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091317ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091317ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091317ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091317ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091317ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091318ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091318ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091318ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091318ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091318ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091318ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091318ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091318ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091318ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091318ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091319ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091319ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091319ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091319ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091319ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091319ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091319ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091319ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091319ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091319ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091320ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091320ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091320ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091320ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091320ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091320ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091320ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091320ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091320ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091320ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091320ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091320ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091320ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091321ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091321ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091321ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091321ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091321ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091321ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091321ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091321ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091321ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091321ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091322ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091322ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091322ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091322ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091322ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091322ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091322ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091322ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091322ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091322ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091323ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091323ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091323ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091323ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091323ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091323ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091323ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091324ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091324ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091324ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091324ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091324ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091324ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091324ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091326ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091326ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091326ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091326ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091326ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091326ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091326ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091326ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091326ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091326ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091326ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091326ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091326ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091328ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091328ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091328ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091328ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091328ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091328ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091328ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091328ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091328ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091328ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091329ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091329ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091329ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091329ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091329ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091329ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091329ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091329ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091329ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091329ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091329ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091329ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091329ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091330ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091330ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091330ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091330ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091330ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091330ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091330ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091330ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091330ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091330ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091330ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091330ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091330ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091331ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091331ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091331ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091331ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091331ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091331ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091331ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091331ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091331ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091331ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091332ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091332ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091332ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091332ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091332ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091332ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091332ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091332ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091332ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091332ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091333ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091333ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091333ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091333ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091333ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091333ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091333ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091333ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091333ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091333ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091334ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091334ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091334ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091334ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091334ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091334ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091334ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091334ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091334ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091334ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091334ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091334ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091334ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091335ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091335ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091335ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091335ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091335ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091335ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091335ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091335ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091335ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091335ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091336ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091336ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091336ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091336ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091336ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091336ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091336ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091336ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091336ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091336ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091336ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091336ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091336ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091337ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091337ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091337ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091337ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091337ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091337ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091337ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091337ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091337ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091337ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091337ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091337ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091337ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091338ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091338ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091338ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091338ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091338ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091338ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091338ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091338ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091338ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091338ECSEQ2ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1009 10091338ECSEQ2FDDTC Date of First Delay 2021-06-23 CRF C4591001ECC4591001 1009 10091338ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091338ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091338ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091338ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091338ECSEQ3ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1009 10091338ECSEQ3FDDTC Date of First Delay 2021-06-23 CRF C4591001ECC4591001 1009 10091339ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091339ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091339ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091339ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091339ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091339ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091339ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091339ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091339ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091339ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091340ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091340ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091340ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091340ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091340ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091340ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091340ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091340ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091340ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091340ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091341ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091341ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091341ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091341ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091341ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091341ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091341ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091341ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091341ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091341ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091341ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091341ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091341ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091342ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091342ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091342ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091342ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091342ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091342ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091342ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091342ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091342ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091342ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091343ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091343ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091343ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091343ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091343ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091343ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091343ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091343ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091343ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091343ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091344ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091344ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091344ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091344ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091344ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091344ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091344ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091344ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091344ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091344ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091344ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091344ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091344ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091345ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091345ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091345ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091345ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091345ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091345ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091345ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091345ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091345ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091345ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091346ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091346ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091346ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091346ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091346ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091346ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091346ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091346ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091346ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091346ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091346ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091346ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091346ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091347ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091347ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091347ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091347ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091347ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091347ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091347ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091347ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091347ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091347ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091347ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091347ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091347ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091348ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091348ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091348ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091348ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091348ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091348ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091348ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091348ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091348ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091348ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091349ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091349ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091349ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091349ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091349ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091349ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091349ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091349ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091349ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091349ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091349ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091349ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091349ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091350ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091350ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091350ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091350ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091350ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091350ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091350ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091350ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091350ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091350ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091350ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091350ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091350ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091351ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091351ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091351ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091351ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091351ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091351ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091351ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091351ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091351ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091351ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091353ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091353ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091353ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091353ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091353ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091353ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091353ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091353ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091353ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091353ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091354ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091354ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091354ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091354ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091354ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091354ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091354ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091354ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091354ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091354ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091355ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091355ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091355ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091355ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091355ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091355ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091355ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091355ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091355ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091355ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091356ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091356ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091356ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091356ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091356ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091356ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091356ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091356ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091356ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091356ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091356ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091356ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091356ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091357ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091357ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091357ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091357ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091357ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091357ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091357ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091357ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091357ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091357ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091357ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091357ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091357ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091358ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091358ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091358ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091358ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091358ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091358ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091358ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091358ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091358ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091358ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091359ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091359ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091359ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091359ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091359ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091359ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091359ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091359ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091359ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091359ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091359ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091359ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091359ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091360ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091360ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091360ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091360ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091360ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091360ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091360ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091360ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091360ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091360ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091361ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091361ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091361ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091361ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091361ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091361ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091361ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091361ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091361ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091361ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091361ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091361ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091361ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091362ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091362ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091362ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091362ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091362ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091362ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091362ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091362ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091362ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091362ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091363ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091363ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091363ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091363ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091363ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091363ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091363ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091363ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091363ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091363ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091363ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091363ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091363ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091363ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091363ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091364ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091364ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091364ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091364ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091364ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091364ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091364ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091364ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091364ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091364ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091365ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091365ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091365ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091365ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091365ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091365ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091365ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091365ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091365ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091365ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091365ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091365ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091365ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091366ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091366ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091366ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091366ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091366ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091366ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091366ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091366ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091366ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091366ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091366ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091366ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091366ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091369ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091369ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091369ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091369ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091369ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091369ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091369ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091369ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091369ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091369ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091369ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091369ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091369ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091370ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091370ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091370ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091370ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091370ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091370ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091370ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091370ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091370ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091370ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091371ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091371ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091371ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091371ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091371ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091371ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091371ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091371ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091371ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091371ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091372ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091372ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091372ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091372ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091372ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091372ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091372ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091372ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091372ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091372ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091373ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091373ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091373ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091373ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091373ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091373ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091373ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091373ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091373ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091373ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091373ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091373ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091373ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091374ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091374ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091374ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091374ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091374ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091374ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091374ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091374ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091374ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091374ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091374ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091374ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091374ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091375ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091375ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091375ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091375ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091375ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091375ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091375ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091375ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091375ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091375ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091376ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091376ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091376ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091376ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091376ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091376ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091376ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091376ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091376ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091376ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091377ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091377ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091377ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091377ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091377ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091377ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091377ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091377ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091377ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091377ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091378ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091378ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091378ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091378ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091378ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091378ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091378ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091378ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091378ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091378ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091378ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091378ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091378ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091379ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091379ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091379ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091379ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091379ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091379ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091379ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091379ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091379ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091379ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091379ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091379ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091379ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091380ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091380ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091380ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091380ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091380ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091380ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091380ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091380ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091380ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091380ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091380ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091380ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091380ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091381ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091381ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091381ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091381ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091381ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091381ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091381ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091381ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091381ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091381ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091382ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091382ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091382ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091382ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091382ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091382ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091382ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091382ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091382ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091382ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091382ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091382ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091382ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091383ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091383ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091383ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091383ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091383ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091383ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091383ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091383ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091383ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091383ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091384ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091384ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091384ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091384ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091384ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091384ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091384ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091384ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091384ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091384ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091384ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091384ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091384ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091385ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091385ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091385ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091385ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091385ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091385ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091385ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091385ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091385ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091385ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091385ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091385ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091385ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091386ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091386ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091386ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091386ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091386ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091386ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091386ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091386ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091386ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091386ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091387ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091387ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091387ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091387ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091387ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091387ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091387ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091387ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091387ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091387ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091388ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091388ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091388ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091388ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091388ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091388ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091388ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091388ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091388ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091388ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091388ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091388ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091388ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091389ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091389ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091389ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091389ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091389ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091389ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091389ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091389ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091389ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091389ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091390ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091390ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091390ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091390ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091390ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091390ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091390ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091390ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091390ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091390ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091390ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091390ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091390ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091391ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091391ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091391ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091391ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091391ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091391ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091391ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091391ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091391ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091391ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091392ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091392ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091392ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091392ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091392ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091392ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091392ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091392ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091392ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091392ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091392ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091392ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091392ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091393ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091393ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091393ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091393ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091393ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091393ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091393ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091393ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091393ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091393ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091394ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091394ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091394ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091394ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091394ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091394ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091394ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091394ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091394ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091394ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091395ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091395ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091395ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091395ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091395ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091395ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091395ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091395ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091395ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091395ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091395ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091395ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091395ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091396ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091396ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091396ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091396ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091396ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091396ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091396ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091396ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091396ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091396ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091398ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091398ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091398ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091398ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091398ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091398ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091398ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091398ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091398ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091398ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091399ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091399ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091399ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091399ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091399ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091399ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091399ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091399ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091399ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091399ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091399ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091399ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091399ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091400ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091400ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091400ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091400ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091400ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091400ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091400ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091400ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091400ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091400ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091400ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091400ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091400ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091400ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091400ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091401ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091401ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091401ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091401ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091401ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091401ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091401ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091401ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091401ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091401ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091401ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091401ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091401ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091402ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091402ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091402ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091402ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091402ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091402ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091402ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091402ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091402ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091402ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091403ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091403ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091403ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091403ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091403ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091403ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091403ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091403ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091403ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091403ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091403ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091403ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091403ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091404ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091404ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091404ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091404ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091404ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091404ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091404ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091404ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091404ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091404ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091405ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091405ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091405ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091405ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091405ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091405ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091405ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091405ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091405ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091405ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091405ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091405ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091405ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091406ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091406ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091406ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091406ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091406ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091406ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091406ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091406ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091406ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091406ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091406ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091406ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091406ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091407ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091407ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091407ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091407ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091407ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091407ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091407ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091407ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091407ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091407ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091408ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091408ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091408ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091408ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091408ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091408ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091408ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091408ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091408ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091408ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091409ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091409ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091409ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091409ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091409ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091409ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091409ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091409ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091409ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091409ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091410ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091410ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091410ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091410ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091410ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091410ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091410ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091410ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091410ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091410ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091411ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091411ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091411ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091411ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091411ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091411ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091411ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091411ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091411ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091411ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091411ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091411ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091411ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091412ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091412ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091412ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091412ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091412ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091412ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091412ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091412ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091412ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091412ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091412ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091412ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1009 10091412ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091413ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091413ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091413ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091413ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091413ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091413ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091413ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091413ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091413ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091413ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1009 10091414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1009 10091414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1009 10091414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1009 10091414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131821ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131821ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131821ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131821ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131821ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131821ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131821ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131821ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131821ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131821ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131822ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131822ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131822ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131822ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131822ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131822ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131822ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131822ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131822ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131822ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131823ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131823ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131823ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131823ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131823ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131823ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131823ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131823ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131823ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131823ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131823ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131823ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131823ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131824ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131824ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131824ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131824ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131824ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131824ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131824ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131824ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131824ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131824ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131826ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131826ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131826ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131826ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131826ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131826ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131826ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131826ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131826ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131826ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131826ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131826ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131826ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131828ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131828ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131828ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131828ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131828ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131828ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131828ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131828ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131828ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131828ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131830ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131830ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131830ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131830ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131830ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131830ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131830ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131830ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131830ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131830ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131835ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131835ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131835ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131835ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131835ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131835ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131835ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131835ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131835ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131835ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131835ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131835ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131835ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131836ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131836ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131836ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131836ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131836ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131836ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131836ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131836ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131836ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131836ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131839ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131839ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131839ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131839ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131839ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131839ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131839ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131839ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131839ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131839ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131841ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131841ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131841ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131841ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131841ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131841ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131841ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131841ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131841ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131841ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131842ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131842ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131842ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131842ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131842ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131842ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131842ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131842ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131842ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131842ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131842ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131842ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131842ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131843ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131843ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131843ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131843ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131843ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131843ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131843ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131843ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131843ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131843ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131844ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131844ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131844ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131844ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131844ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131844ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131844ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131844ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131844ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131844ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131844ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131844ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131844ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131845ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131845ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131845ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131845ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131845ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131845ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131845ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131845ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131845ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131845ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131846ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131846ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131846ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131846ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131846ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131846ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131846ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131846ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131846ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131846ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131848ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131848ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131848ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131848ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131848ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131848ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131848ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131848ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131848ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131848ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131850ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131850ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131850ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131850ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131850ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131850ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131850ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131850ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131850ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131850ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131851ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131851ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131851ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131851ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131851ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131851ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131851ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131851ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131851ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131851ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131851ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131851ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131851ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131852ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131852ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131852ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131852ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131852ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131852ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131852ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131852ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131852ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131852ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131852ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131852ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131852ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131855ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131855ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131855ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131855ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131855ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131855ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131855ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131855ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131855ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131855ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131856ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131856ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131856ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131856ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131856ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131856ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131856ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131856ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131856ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131856ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131858ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131858ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131858ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131858ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131858ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131858ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131858ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131858ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131858ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131858ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131858ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131858ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131858ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131859ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131859ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131859ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131859ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131859ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131859ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131859ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131859ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131859ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131859ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131860ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131860ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131860ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131860ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131860ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131860ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131860ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131860ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131860ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131860ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131860ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131860ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131860ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131861ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131861ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131861ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131861ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131861ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131861ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131861ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131861ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131861ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131861ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131862ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131862ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131862ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131862ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131862ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131862ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131862ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131862ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131862ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131862ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131863ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131863ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131863ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131863ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131863ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131863ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131863ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131863ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131863ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131863ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131863ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131863ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131863ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131865ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131865ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131865ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131865ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131865ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131865ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131865ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131865ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131865ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131865ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131866ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131866ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131866ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131866ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131866ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131866ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131866ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131866ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131866ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131866ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131867ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131867ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131867ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131867ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131867ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131867ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131867ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131867ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131867ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131867ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131867ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131867ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131867ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131868ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131868ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131868ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131868ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131868ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131868ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131868ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131868ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131868ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131868ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131869ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131869ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131869ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131869ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131869ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131869ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131869ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131869ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131869ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131869ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131870ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131870ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131870ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131870ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131870ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131870ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131870ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131870ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131870ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131870ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131871ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131871ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131871ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131871ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131871ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131871ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131871ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131871ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131871ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131871ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131872ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131872ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131872ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131872ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131872ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131872ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131872ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131872ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131872ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131872ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131873ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131873ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131873ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131873ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131873ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131873ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131873ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131873ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131873ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131873ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131874ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131874ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131874ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131874ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131874ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131874ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131874ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131874ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131874ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131874ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131874ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131874ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131874ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131875ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131875ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131875ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131875ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131875ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131875ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131875ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131875ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131875ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131875ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131875ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131875ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131875ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131876ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131876ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131876ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131876ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131876ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131876ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131876ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131876ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131876ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131876ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131877ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131877ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131877ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131877ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131877ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131877ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131877ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131877ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131877ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131877ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131878ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131878ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131878ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131878ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131878ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131878ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131878ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131878ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131878ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131878ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131879ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131879ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131879ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131879ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131879ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131879ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131879ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131879ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131879ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131879ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131879ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131879ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131879ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131880ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131880ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131880ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131880ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131880ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131880ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131880ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131880ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131880ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131880ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131881ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131881ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131881ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131881ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131881ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131881ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131881ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131881ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131881ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131881ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131882ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131882ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131882ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131882ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131882ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131882ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131882ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131882ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131882ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131882ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131882ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131882ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131882ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131883ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131883ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131883ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131883ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131883ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131883ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131883ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131883ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131883ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131883ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131883ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131883ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131883ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131884ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131884ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131884ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131884ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131884ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131884ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131884ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131884ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131884ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131884ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131885ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131885ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131885ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131885ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131885ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131885ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131885ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131885ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131885ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131885ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131885ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131885ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131885ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131886ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131886ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131886ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131886ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131886ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1013 10131886ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131886ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131886ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131886ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1013 10131886ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1013 10131886ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1013 10131886ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1013 10131886ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161307ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161307ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161307ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161307ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161307ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161307ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161307ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161307ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161307ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161307ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161307ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161307ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161307ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161308ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161308ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161308ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161308ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161308ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161308ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161308ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161308ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161308ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161308ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161308ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161308ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161308ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161309ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161309ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161309ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161309ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161309ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161309ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161309ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161309ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161309ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161309ECSEQ2ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1016 10161309ECSEQ2FDDTC Date of First Delay 2020-11-04 CRF C4591001ECC4591001 1016 10161310ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161310ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161310ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161310ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161310ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161310ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161310ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161310ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161310ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161310ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161311ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161311ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161311ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161311ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161311ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161311ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161311ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161311ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161311ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161311ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161314ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161314ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161314ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161314ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161314ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161314ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161314ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161314ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161314ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161314ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161315ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161315ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161315ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161315ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161315ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161315ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161315ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161315ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161315ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161315ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161315ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161315ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161315ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161316ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161316ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161316ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161316ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161316ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161316ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161316ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161316ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161316ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161316ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161316ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161316ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161316ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161316ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161316ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161318ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161318ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161318ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161318ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161318ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161318ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161318ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161318ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161318ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161318ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161318ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161318ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161318ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161319ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161319ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161319ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161319ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161319ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161319ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161319ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161319ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161319ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161319ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161319ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161319ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161319ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161320ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161320ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161320ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161320ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161320ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1016 10161320ECSEQ1FDDTC Date of First Delay 2020-10-19 CRF C4591001ECC4591001 1016 10161320ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161320ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161320ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161320ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161320ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161322ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161322ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161322ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161322ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161322ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161322ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161322ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161322ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161322ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161322ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161324ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161324ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161324ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161324ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161324ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161324ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161324ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161326ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161326ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161326ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161326ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161326ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161326ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161326ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161326ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161326ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161326ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161327ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161327ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161327ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161327ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161327ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161327ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161327ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161327ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161327ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161327ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161327ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161327ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161327ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161329ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161329ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161329ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161329ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161329ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161329ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161329ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161329ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161329ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161329ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161329ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161329ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161329ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161330ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161330ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161330ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161330ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161330ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161330ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161330ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161330ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161330ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161330ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161331ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161331ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161331ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161331ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161331ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161331ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161331ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161331ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161331ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161331ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161331ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161331ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161331ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161332ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161332ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161332ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161332ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161332ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161332ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161332ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161332ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161332ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161332ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161334ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161334ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161334ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161334ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161334ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161334ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161334ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161334ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161334ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161334ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161334ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161334ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161334ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161335ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161335ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161335ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161335ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161335ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161335ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161335ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161335ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161335ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161335ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161336ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161336ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161336ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161336ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161336ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161336ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161336ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161336ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161336ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161336ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161336ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161336ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161336ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161337ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161337ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161337ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161337ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161337ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161337ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161337ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161337ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161337ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161337ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161337ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161337ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161337ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161338ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161338ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161338ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161338ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161338ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161338ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161338ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161338ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161338ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161338ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161339ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161339ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161339ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161339ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161339ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161339ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161339ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161339ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161339ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161339ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161340ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161340ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161340ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161340ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161340ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161340ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161340ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161340ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161340ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161340ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161340ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161340ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161340ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161343ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161343ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161343ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161343ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161343ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161343ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161343ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161343ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161343ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161343ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161344ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161344ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161344ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161344ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161344ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161344ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161344ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161344ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161344ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161344ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161344ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161344ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161344ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161350ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161350ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161350ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161350ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161350ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161350ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161350ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161350ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161350ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161350ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161351ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161351ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161351ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161351ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161351ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161351ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161351ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161351ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161351ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161351ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161351ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161351ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161351ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161352ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161352ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161352ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161352ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161352ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161352ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161352ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161352ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161352ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161352ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161352ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161352ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161352ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161353ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161353ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161353ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161353ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161353ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161353ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161353ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161353ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161353ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161353ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161353ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161353ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161353ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161354ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161354ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161354ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161354ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161354ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161354ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161354ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161354ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161354ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161354ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161356ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161356ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161356ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161356ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161356ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161356ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161356ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161356ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161356ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161356ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161357ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161357ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161357ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161357ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161357ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161357ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161357ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161357ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161357ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161357ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161358ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161358ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161358ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161358ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161358ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161358ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161358ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161358ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161358ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161358ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161361ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161361ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161361ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161361ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161361ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161361ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161361ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161361ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161361ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161361ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161361ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161361ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161361ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161362ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161362ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161362ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161362ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161362ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161362ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161362ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161362ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161362ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161362ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161363ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161363ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161363ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161363ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161363ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161363ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161363ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161363ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161363ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161363ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161364ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161364ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161364ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161364ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161364ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161364ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161364ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161364ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161364ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161364ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161365ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161365ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161365ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161365ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161365ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161365ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161365ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161365ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161365ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161365ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161365ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161365ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161365ECSEQ4ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1016 10161365ECSEQ4FDDTC Date of First Delay 2021-06-07 CRF C4591001ECC4591001 1016 10161366ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161366ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161366ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161366ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161366ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161366ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161366ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161366ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161366ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161366ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161366ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161366ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161366ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161367ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161367ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161367ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161367ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161367ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161367ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161367ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161367ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161367ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161367ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161367ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161367ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161367ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161368ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161368ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161368ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161368ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161368ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161368ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161368ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161368ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161368ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161368ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161368ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161368ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161368ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161369ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161369ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161369ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161369ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161369ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161369ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161369ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161369ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161369ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161369ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161370ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161370ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161370ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161370ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161370ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161370ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161370ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161370ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161370ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161370ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161371ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161371ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161371ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161371ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161371ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161371ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161371ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161371ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161371ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161371ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161371ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161371ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161371ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161372ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161372ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161372ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161372ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161372ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161372ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161372ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161372ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161372ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161372ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161372ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161372ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161372ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161373ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161373ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161373ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161373ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161373ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161373ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161373ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161373ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161373ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161373ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161374ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161374ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161374ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161374ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161374ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161374ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161374ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161374ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161374ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161374ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161375ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161375ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161375ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161375ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161375ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161375ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161375ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161375ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161375ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161375ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161375ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161375ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161375ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161376ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161376ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161376ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161376ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161376ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161376ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161376ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161376ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161376ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161376ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161377ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161377ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161377ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161377ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161377ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161377ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161377ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161377ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161377ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161377ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161378ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161378ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161378ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161378ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161378ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161378ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161378ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161378ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161378ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161378ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161378ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161378ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161378ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161379ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161379ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161379ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161379ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161379ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161379ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161379ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161379ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161379ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161379ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161379ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161379ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161379ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161379ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161379ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161381ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161381ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161381ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161381ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161381ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161381ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161381ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161381ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161381ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161381ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161382ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161382ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161382ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161382ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161382ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161382ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161382ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161382ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161382ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161382ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161383ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161383ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161383ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161383ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161383ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161383ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161383ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161383ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161383ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161383ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161383ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161383ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161383ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161384ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161384ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161384ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161384ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161384ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161384ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161384ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161384ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161384ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161384ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161385ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161385ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161385ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161385ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161385ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161385ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161385ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161385ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161385ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161385ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161386ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161386ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161386ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161386ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161386ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161386ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161386ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161386ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161386ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161386ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161386ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161386ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161386ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161387ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161387ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161387ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161387ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161387ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161387ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161387ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161387ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161387ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161387ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161388ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161388ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161388ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161388ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161388ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1016 10161388ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161388ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161388ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161388ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1016 10161388ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1016 10161388ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1016 10161388ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1016 10161388ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391246ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391246ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391246ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391246ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391246ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391246ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391246ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391246ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391246ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391246ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391246ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391246ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391246ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391247ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391247ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391247ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391247ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391247ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391247ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391247ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391247ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391247ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391247ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391251ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391251ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391251ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391251ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391251ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391251ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391251ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391251ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391251ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391251ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391251ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391251ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391251ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391252ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391252ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391252ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391252ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391252ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391252ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391252ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391252ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391252ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391252ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391252ECSEQ4ECOBSV Observed Post Dose For Specified TimeN CRF C4591001ECC4591001 1039 10391252ECSEQ4ECOBSVDDetails Of Subject Observation Subject left before 30 minutes against site instructions. Deviation noted. CRF C4591001ECC4591001 1039 10391252ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391252ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391255ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391255ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391255ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391255ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391255ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391255ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391255ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391255ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391255ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391255ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391256ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391256ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391256ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391256ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391256ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391256ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391256ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391256ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391256ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391256ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391256ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391256ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391256ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391258ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391258ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391258ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391258ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391258ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391258ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391258ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391258ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391258ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391258ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391258ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391258ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391258ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391259ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391259ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391259ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391259ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391259ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391259ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391259ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391259ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391259ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391259ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391259ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391259ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391259ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391260ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391260ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391260ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391260ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391260ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391260ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391260ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391260ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391260ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391260ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391262ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391262ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391262ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391262ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391262ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391262ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391262ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391262ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391262ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391262ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391264ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391264ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391264ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391264ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391264ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391264ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391264ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391264ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391264ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391264ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391264ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391264ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391264ECSEQ3ECOBSV Observed Post Dose For Specified TimeN CRF C4591001ECC4591001 1039 10391264ECSEQ3ECOBSVDDetails Of Subject Observation Patient left 7 minutes early due to parent's work emergency. CRF C4591001ECC4591001 1039 10391264ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391264ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391265ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391265ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391265ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391265ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391265ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391265ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391265ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391265ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391265ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391265ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391266ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391266ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391266ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391266ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391266ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391266ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391266ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391266ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391266ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391266ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391266ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391266ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391266ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391267ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391267ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391267ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391267ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391267ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391267ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391267ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391267ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391267ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391267ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391268ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391268ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391268ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391268ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391268ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391268ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391268ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391268ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391268ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391268ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391268ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391268ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391268ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391269ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391269ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391269ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391269ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391269ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391269ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391269ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391269ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391269ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391269ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391270ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391270ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391270ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391270ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391270ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391270ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391270ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391271ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391271ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391271ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391271ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391271ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391271ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391271ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391271ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391271ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391271ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391271ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391271ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391271ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391272ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391272ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391272ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391272ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391272ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391272ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391272ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391272ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391272ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391272ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391273ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391273ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391273ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391273ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391273ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391273ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391273ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391274ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391274ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391274ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391274ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391274ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391274ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391274ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391276ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391276ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391276ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391276ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391276ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391276ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391276ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391276ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391276ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391276ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391277ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391277ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391277ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391277ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391277ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391277ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391277ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391279ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391279ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ3ECOBSV Observed Post Dose For Specified TimeN CRF C4591001ECC4591001 1039 10391279ECSEQ3ECOBSVDDetails Of Subject Observation subject left 10 min before end of 30 min due to mom's work emergency. Deviation has been filedCRF C4591001ECC4591001 1039 10391279ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391279ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391279ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391279ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391279ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391279ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391280ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391280ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391280ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391280ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391280ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391280ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391280ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391281ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391281ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391281ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391281ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391281ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391281ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391281ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391281ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391281ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391281ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391283ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391283ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391283ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391283ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391283ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391283ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391283ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391285ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391285ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391285ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391285ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391285ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391285ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391285ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391287ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391287ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391287ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391287ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391287ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391287ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391287ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391287ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391287ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391290ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391291ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391291ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391291ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391291ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391291ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391291ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391291ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391292ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391292ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391292ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391292ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391293ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391293ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391293ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391293ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391293ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391293ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391293ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391293ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391293ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391293ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391294ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391294ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391294ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391294ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391294ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391294ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391294ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391296ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391296ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391296ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391296ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391296ECSEQ4ECOBSV Observed Post Dose For Specified TimeN CRF C4591001ECC4591001 1039 10391296ECSEQ4ECOBSVDDetails Of Subject Observation Staff oversight CRF C4591001ECC4591001 1039 10391296ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391296ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391299ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391299ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391299ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391299ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391299ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391299ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391299ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391301ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391301ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391301ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391301ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391301ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391301ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391301ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391301ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391301ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391301ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391301ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391301ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391301ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391302ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391302ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391302ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391302ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391302ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391302ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391302ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391302ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391302ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391302ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391303ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391303ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391303ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391303ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391303ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391303ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391303ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391303ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391303ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391303ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391303ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391303ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391303ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391304ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391304ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391304ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391304ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391304ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391304ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391304ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391304ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391304ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391304ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391305ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391305ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391305ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391305ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391305ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391305ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391305ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391305ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391305ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391305ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391305ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391305ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391305ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391306ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391306ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391306ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391306ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391306ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391306ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391306ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391306ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391306ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391306ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391307ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391307ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391307ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391307ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391307ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391307ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391307ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391307ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391307ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391307ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391307ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391307ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391307ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391308ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391308ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391308ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391308ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391308ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391308ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391308ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391308ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391308ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391308ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391309ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391309ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391309ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391309ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391309ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391309ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391309ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391309ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391309ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391309ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391309ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391309ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391309ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391310ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391310ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391310ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391310ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391310ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391310ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391310ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391310ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391310ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391310ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391310ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391310ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391310ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391311ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391311ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391311ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391311ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391311ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391311ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391311ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391311ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391311ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391311ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391312ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391312ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391312ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391312ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391312ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391312ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391312ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391312ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391312ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391312ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391313ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391313ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391313ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391313ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391313ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391313ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391313ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391313ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391313ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391313ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391313ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391313ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391313ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391314ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391314ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391314ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391314ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391314ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391314ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391314ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391314ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391314ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391314ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391314ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391314ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391314ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391315ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391315ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391315ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391315ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391315ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391315ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391315ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391315ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391315ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391315ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391316ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391316ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391316ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391316ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391316ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391316ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391316ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391316ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391316ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391316ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391317ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391317ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391317ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391317ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391317ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391317ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391317ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391317ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391317ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391317ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391317ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391317ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391317ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391318ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391318ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391318ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391318ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391318ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391318ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391318ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391318ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391318ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391318ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391319ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391319ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391319ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391319ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391319ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391319ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391319ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391319ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391319ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391319ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391319ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391319ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391319ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391320ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391320ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391320ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391320ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391320ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391320ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391320ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391320ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391320ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391320ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391321ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391321ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391321ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391321ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391321ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391321ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391321ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391321ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391321ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391321ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391321ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391321ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391321ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391322ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391322ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391322ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391322ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391322ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391322ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391322ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391322ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391322ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391322ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391325ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391325ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391325ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391325ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391325ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391325ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391325ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391326ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391326ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391326ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391326ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391326ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391326ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391326ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391326ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391326ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391326ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391327ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391327ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391327ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391327ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391327ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391327ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391327ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391327ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391327ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391327ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391328ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391328ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391328ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391328ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391328ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391328ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391328ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391328ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391328ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391328ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391328ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391328ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391328ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391329ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391329ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391329ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391329ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391329ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391329ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391329ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391329ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391329ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391329ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391329ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391329ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391329ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391330ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391330ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391330ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391330ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391330ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391330ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391330ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391330ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391330ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391330ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391331ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391331ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391331ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391331ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391331ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391331ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391331ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391331ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391331ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391331ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391332ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391332ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391332ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391332ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391332ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391332ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391332ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391332ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391332ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391332ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391333ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391333ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391333ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391333ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391333ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391333ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391333ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391333ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391333ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391333ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391333ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391333ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391333ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391334ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391334ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391334ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391334ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391334ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391334ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391334ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391334ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391334ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391334ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391334ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391334ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391334ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391335ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391335ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391335ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391335ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391335ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391335ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391335ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391335ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391335ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391335ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391336ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391336ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391336ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391336ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391336ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391336ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391336ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391336ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391336ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391336ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391337ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391337ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391337ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391337ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391337ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391337ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391337ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391337ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391337ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391337ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391337ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391337ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391337ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391338ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391338ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391338ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391338ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391338ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391338ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391338ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391338ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391338ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391338ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391339ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391339ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391339ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391339ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391339ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1039 10391339ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391339ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391339ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391339ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1039 10391339ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1039 10391339ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1039 10391339ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1039 10391339ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441251ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441251ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441251ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441251ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441251ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441251ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441251ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441251ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441251ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441251ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441252ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441252ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441252ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441252ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441252ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441252ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441252ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441252ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441252ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441252ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441252ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441252ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441252ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441255ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441255ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441255ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441255ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441255ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441255ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441255ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441255ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441255ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441255ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441256ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441256ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441256ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441256ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441256ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441256ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441256ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441256ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441256ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441256ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441256ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441256ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441256ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441257ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441257ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441257ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441257ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441257ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441257ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441257ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441257ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441257ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441257ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441259ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441259ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441259ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441259ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441259ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441259ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441259ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441259ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441259ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441259ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441260ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441260ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441260ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441260ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441260ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441260ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441260ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441260ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441260ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441260ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441260ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441260ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441260ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441261ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441261ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441261ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441261ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441261ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441261ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441261ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441261ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441261ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441261ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441261ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441261ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441261ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441264ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441264ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441264ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441264ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441264ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441264ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441264ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441264ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441264ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441264ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441264ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441264ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441264ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441265ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441265ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441265ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441265ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441265ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441265ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441265ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441265ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441265ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441265ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441265ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441265ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441265ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441266ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441266ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441266ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441266ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441266ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441266ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441266ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441266ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441266ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441266ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441267ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441267ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441267ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441267ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441267ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441267ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441267ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441267ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441267ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441267ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441267ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441267ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441267ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441268ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441268ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441268ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441268ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441268ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441268ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441268ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441268ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441268ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441268ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441271ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441271ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441271ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441271ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441271ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441271ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441271ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441271ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441271ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441271ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441274ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441274ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441274ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441274ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441274ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441274ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441274ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441275ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441275ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441275ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441275ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441275ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441275ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441275ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441276ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441276ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441276ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441276ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441276ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441276ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441276ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441276ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441276ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441276ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441277ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441277ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441277ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441277ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441277ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441277ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441277ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441279ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441280ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441280ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441280ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441280ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441280ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441280ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441280ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441281ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441281ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441281ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441281ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441281ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441281ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441281ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441281ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441281ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441281ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441282ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441282ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441282ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441282ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441282ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441282ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441282ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441284ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441284ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441284ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441284ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441284ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441284ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441284ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441286ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441286ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441286ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441286ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441286ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441286ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441286ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441290ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1044 10441290ECSEQ1FDDTC Date of First Delay 2020-12-16 CRF C4591001ECC4591001 1044 10441290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441292ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441292ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441292ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441292ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441293ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441293ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441293ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441293ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441293ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441293ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441293ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441293ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441293ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441293ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441293ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441293ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441293ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441293ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441293ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441294ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441294ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441294ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441294ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441294ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441298ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441298ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441298ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441298ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441298ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441298ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441298ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441299ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441299ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441299ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441299ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441299ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441299ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441299ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441301ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441301ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441301ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441301ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441301ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441301ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441301ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441301ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441301ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441301ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441302ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441302ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441302ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441302ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441302ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441302ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441302ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441302ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441302ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441302ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441302ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441302ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441302ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441303ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441303ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441303ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441303ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441303ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441303ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441303ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441303ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441303ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441303ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441303ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441303ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441303ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441304ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441304ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441304ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441304ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441304ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441304ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441304ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441304ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441304ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441304ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441306ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441306ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441306ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441306ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441306ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441306ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441306ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441306ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441306ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441306ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441307ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441307ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441307ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441307ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441307ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441307ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441307ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441307ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441307ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441307ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441307ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441307ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441307ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441307ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441307ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441308ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441308ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441308ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441308ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441308ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441308ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441308ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441308ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441308ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441308ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441308ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441308ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441308ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441309ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441309ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441309ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441309ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441309ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441309ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441309ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441309ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441309ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441309ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441310ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441310ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441310ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441310ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441310ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441310ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441310ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441310ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441310ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441310ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441311ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441311ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441311ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441311ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441311ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441311ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441311ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441311ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441311ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441311ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441312ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441312ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441312ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441312ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441312ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441312ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441312ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441312ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441312ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441312ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441312ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441312ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441312ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441313ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441313ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441313ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441313ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441313ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441313ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441313ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441313ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441313ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441313ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441313ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441313ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441313ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441314ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441314ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441314ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441314ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441314ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441314ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441314ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441314ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441314ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441314ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441315ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441315ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441315ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441315ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441315ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441315ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441315ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441315ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441315ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441315ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441315ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441315ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441315ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441316ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441316ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441316ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441316ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441316ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441316ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441316ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441316ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441316ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441316ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441317ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441317ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441317ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441317ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441317ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441317ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441317ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441317ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441317ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441317ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441317ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441317ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441317ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441318ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441318ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441318ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441318ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441318ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441318ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441318ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441318ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441318ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441318ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441318ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441318ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441318ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441319ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441319ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441319ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441319ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441319ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441319ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441319ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441319ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441319ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441319ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441320ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441320ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441320ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441320ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441320ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441320ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441320ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441320ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441320ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441320ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441320ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441320ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441320ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441321ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441321ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441321ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441321ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441321ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441321ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441321ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441321ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441321ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441321ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441322ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441322ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441322ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441322ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441322ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441322ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441322ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441322ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441322ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441322ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441323ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441323ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441323ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441323ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441323ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441323ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441323ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441324ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441324ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441324ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441324ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441324ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441324ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441324ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441326ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441326ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441326ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441326ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441326ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441326ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441326ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441326ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441326ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441326ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441326ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441326ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441326ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441327ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441327ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441327ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441327ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441327ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441327ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441327ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441327ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441327ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441327ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441327ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441327ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441327ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441328ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441328ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441328ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441328ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441328ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441328ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441328ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441328ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441328ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441328ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441329ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441329ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441329ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441329ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441329ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441329ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441329ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441329ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441329ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441329ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441330ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441330ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441330ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441330ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441330ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441330ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441330ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441330ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441330ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441330ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441330ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441330ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441330ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441331ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441331ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441331ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441331ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441331ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441331ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441331ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441331ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441331ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441331ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441332ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441332ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441332ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441332ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441332ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441332ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441332ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441332ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441332ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441332ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441332ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441332ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441332ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441333ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441333ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441333ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441333ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441333ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441333ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441333ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441333ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441333ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441333ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441334ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441334ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441334ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441334ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441334ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441334ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441334ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441334ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441334ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441334ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441335ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441335ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441335ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441335ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441335ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441335ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441335ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441335ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441335ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441335ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441335ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441335ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441335ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441336ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441336ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441336ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441336ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441336ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441336ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441336ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441336ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441336ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441336ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441337ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441337ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441337ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441337ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441337ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441337ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441337ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441337ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441337ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441337ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441337ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441337ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441337ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441338ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441338ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441338ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441338ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441338ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441338ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441338ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441338ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441338ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441338ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441339ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441339ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441339ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441339ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441339ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441339ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441339ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441339ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441339ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441339ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441340ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441340ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441340ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441340ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441340ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441340ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441340ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441340ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441340ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441340ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441340ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441340ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441340ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441341ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441341ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441341ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441341ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441341ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441341ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441341ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441341ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441341ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441341ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441341ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441341ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441341ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441342ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441342ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441342ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441342ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441342ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441342ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441342ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441342ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441342ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441342ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441343ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441343ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441343ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441343ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441343ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441343ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441343ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441343ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441343ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441343ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441344ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441344ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441344ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441344ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441344ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441344ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441344ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441344ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441344ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441344ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441344ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441344ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441344ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441345ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441345ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441345ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441345ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441345ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441345ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441345ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441345ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441345ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441345ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441345ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441345ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441345ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441346ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441346ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441346ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441346ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441346ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441346ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441346ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441346ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441346ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441346ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441347ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441347ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441347ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441347ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441347ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441347ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441347ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441347ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441347ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441347ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441348ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441348ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441348ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441348ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441348ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441348ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441348ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441348ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441348ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441348ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441348ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441348ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441348ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441349ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441349ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441349ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441349ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441349ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441349ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441349ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441349ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441349ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441349ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441350ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441350ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441350ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441350ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441350ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441350ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441350ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441350ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441350ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441350ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441351ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441351ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441351ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441351ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441351ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441351ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441351ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441351ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441351ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441351ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441351ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441351ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441351ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441352ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441352ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441352ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441352ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441352ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441352ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441352ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441352ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441352ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441352ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441353ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441353ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441353ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441353ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441353ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441353ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441353ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441353ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441353ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441353ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441354ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441354ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441354ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441354ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441354ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441354ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441354ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441354ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441354ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441354ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441354ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441354ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441354ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441355ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441355ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441355ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441355ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441355ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441355ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441355ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441355ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441355ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441355ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441356ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441356ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441356ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441356ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441356ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441356ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441356ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441356ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441356ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441356ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441357ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441357ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441357ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441357ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441357ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441357ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441357ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441357ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441357ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441357ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441357ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441357ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441357ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441358ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441358ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441358ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441358ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441358ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441358ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441358ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441358ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441358ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441358ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441359ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441359ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441359ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441359ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441359ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441359ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441359ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441359ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441359ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441359ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441360ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441360ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441360ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441360ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441360ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441360ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441360ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441360ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441360ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441360ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441360ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441360ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441360ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441361ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441361ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441361ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441361ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441361ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441361ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441361ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441361ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441361ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441361ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441362ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441362ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441362ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441362ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441362ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441362ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441362ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441362ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441362ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441362ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441362ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441362ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441362ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441363ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441363ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441363ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441363ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441363ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441363ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441363ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441363ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441363ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441363ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441363ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441363ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441363ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441364ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441364ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441364ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441364ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441364ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441364ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441364ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441364ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441364ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441364ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441365ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441365ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441365ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441365ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441365ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441365ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441365ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441365ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441365ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441365ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441365ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441365ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441365ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441366ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441366ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441366ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441366ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441366ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441366ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441366ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441366ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441366ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441366ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441367ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441367ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441367ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441367ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441367ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441367ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441367ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441367ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441367ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441367ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441368ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441368ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441368ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441368ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441368ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441368ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441368ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441368ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441368ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441368ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441368ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441368ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441368ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441369ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441369ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441369ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441369ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441369ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441369ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441369ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441369ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441369ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441369ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441370ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441370ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441370ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441370ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441370ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441370ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441370ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441370ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441370ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441370ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441370ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441370ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441370ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441371ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441371ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441371ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441371ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441371ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441371ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441371ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441371ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441371ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441371ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441372ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441372ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441372ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441372ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441372ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441372ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441372ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441372ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441372ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441372ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441373ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441373ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441373ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441373ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441373ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441373ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441373ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441373ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441373ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441373ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441373ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441373ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441373ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441374ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441374ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441374ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441374ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441374ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441374ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441374ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441374ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441374ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441374ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441374ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441374ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441374ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441374ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441374ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441375ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441375ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441375ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441375ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441375ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441375ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441375ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441375ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441375ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441375ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441376ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441376ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441376ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441376ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441376ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441376ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441376ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441376ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441376ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441376ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441377ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441377ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441377ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441377ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441377ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1044 10441377ECSEQ1FDDTC Date of First Delay 2021-01-12 CRF C4591001ECC4591001 1044 10441377ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441377ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441377ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441377ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441377ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441378ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441378ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441378ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441378ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441378ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441378ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441378ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441378ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441378ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441378ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441379ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441379ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441379ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441379ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441379ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441379ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441379ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441379ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441379ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441379ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441380ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441380ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441380ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441380ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441380ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441380ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441380ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441380ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441380ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441380ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441380ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441380ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441380ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441381ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441381ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441381ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441381ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441381ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441381ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441381ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441381ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441381ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441381ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441381ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441381ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441381ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441382ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441382ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441382ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441382ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441382ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441382ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441382ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441382ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441382ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441382ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441382ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441382ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441382ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441383ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441383ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441383ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441383ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441383ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441383ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441383ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441383ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441383ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441383ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441384ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441384ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441384ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441384ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441384ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1044 10441384ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441384ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441384ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441384ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1044 10441384ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1044 10441384ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1044 10441384ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1044 10441384ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571376ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571376ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571376ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571376ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571376ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571376ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571376ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571376ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571376ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571376ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571377ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571377ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571377ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571377ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571377ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571377ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571377ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571377ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571377ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571377ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571378ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571378ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571378ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571378ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571378ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571378ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571378ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571378ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571378ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571378ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571379ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571379ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571379ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571379ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571379ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571379ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571379ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571379ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571379ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571379ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571379ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571379ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571379ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571380ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571380ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571380ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571380ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571380ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571380ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571380ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571380ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571380ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571380ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571382ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571382ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571382ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571382ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571382ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571382ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571382ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571382ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571382ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571382ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571383ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571383ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571383ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571383ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571383ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571383ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571383ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571383ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571383ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571383ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571383ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571383ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571383ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571384ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571384ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571384ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571384ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571384ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571384ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571384ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571384ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571384ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571384ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571384ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571384ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571384ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571385ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571385ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571385ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571385ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571385ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571385ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571385ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571385ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571385ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571385ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571386ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571386ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571386ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571386ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571386ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571386ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571386ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571386ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571386ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571386ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571387ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571387ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571387ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571387ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571387ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571387ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571387ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571387ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571387ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571387ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571387ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571387ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571387ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571388ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571388ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571388ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571388ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571388ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571388ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571388ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571388ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571388ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571388ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571389ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571389ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571389ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571389ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571389ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571389ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571389ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571389ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571389ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571389ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571390ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571390ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571390ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571390ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571390ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571390ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571390ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571390ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571390ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571390ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571391ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571391ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571391ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571391ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571391ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571391ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571391ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571391ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571391ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571391ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571391ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571391ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571391ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571392ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571392ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571392ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571392ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571392ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571392ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571392ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571392ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571392ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571392ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571393ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571393ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571393ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571393ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571393ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571393ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571393ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571393ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571393ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571393ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571393ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571393ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571393ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571394ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571394ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571394ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571394ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571394ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571394ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571394ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571394ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571394ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571394ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571394ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571394ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571394ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571395ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571395ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571395ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571395ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571395ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571395ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571395ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571395ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571395ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571395ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571396ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571396ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571396ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571396ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571396ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571396ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571396ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571396ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571396ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571396ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571397ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571397ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571397ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571397ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571397ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571397ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571397ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571397ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571397ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571397ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571398ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571398ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571398ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571398ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571398ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571398ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571398ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571398ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571398ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571398ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571398ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571398ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571398ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571399ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571399ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571399ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571399ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571399ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571399ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571399ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571399ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571399ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571399ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571400ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571400ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571400ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571400ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571400ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571400ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571400ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571400ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571400ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571400ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571400ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571400ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571400ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571401ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571401ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571401ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571401ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571401ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571401ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571401ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571401ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571401ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571401ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571402ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571402ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571402ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571402ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571402ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571402ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571402ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571402ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571402ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571402ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571402ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571402ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571402ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571403ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571403ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571403ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571403ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571403ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571403ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571403ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571403ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571403ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571403ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571404ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571404ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571404ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571404ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571404ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571404ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571404ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571404ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571404ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571404ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571404ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571404ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571404ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571405ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571405ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571405ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571405ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571405ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571405ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571405ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571405ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571405ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571405ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571406ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571406ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571406ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571406ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571406ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571406ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571406ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571406ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571406ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571406ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571406ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571406ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571406ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571407ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571407ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571407ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571407ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571407ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571407ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571407ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571407ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571407ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571407ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571407ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571407ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571407ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571408ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571408ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571408ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571408ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571408ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571408ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571408ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571408ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571408ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571408ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571408ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571408ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571408ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571409ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571409ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571409ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571409ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571409ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571409ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571409ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571409ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571409ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571409ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571410ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571410ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571410ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571410ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571410ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571410ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571410ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571410ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571410ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571410ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571410ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571410ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571410ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571411ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571411ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571411ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571411ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571411ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571411ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571411ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571411ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571411ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571411ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571412ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571412ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571412ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571412ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571412ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571412ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571412ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571412ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571412ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571412ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571415ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571415ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571415ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571415ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571415ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571415ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571415ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571415ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571415ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571415ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571415ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571415ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571415ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571416ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571416ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571416ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571416ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571416ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571416ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571416ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571416ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571416ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571416ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571417ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571417ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571417ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571417ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571417ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571417ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571417ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571417ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571417ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571417ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571417ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571417ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571417ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571418ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571418ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571418ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571418ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571418ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571418ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571418ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571418ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571418ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571418ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571419ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571419ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571419ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571419ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571419ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571419ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571419ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571419ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571419ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571419ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571420ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571420ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571420ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571420ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571420ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571420ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571420ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571420ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571420ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571420ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571421ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571421ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571421ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571421ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571421ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571421ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571421ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571421ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571421ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571421ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571422ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571422ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571422ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571422ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571422ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571422ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571422ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571422ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571422ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571422ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571423ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571423ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571423ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571423ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571423ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571423ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571423ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571423ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571423ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571423ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571424ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571424ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571424ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571424ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571424ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571424ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571424ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571424ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571424ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571424ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571424ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571424ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571424ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571425ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571425ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571425ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571425ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571425ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571425ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571425ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571425ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571425ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571425ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571426ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571426ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571426ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571426ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571426ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571426ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571426ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571426ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571426ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571426ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571427ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571427ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571427ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571427ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571427ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571427ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571427ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571427ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571427ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571427ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571429ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571429ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571429ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571429ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571429ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571429ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571429ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571429ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571429ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571429ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571430ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571430ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571430ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571430ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571430ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571430ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571430ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571430ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571430ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571430ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571431ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571431ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571431ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571431ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571431ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571431ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571431ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571431ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571431ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571431ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571431ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571431ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571431ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571432ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571432ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571432ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571432ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571432ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571432ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571432ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571432ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571432ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571432ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571432ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571432ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571432ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571433ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571433ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571433ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571433ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571433ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571433ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571433ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571433ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571433ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571433ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571434ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571434ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571434ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571434ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571434ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571434ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571434ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571434ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571434ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571434ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571434ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571434ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571434ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571435ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571435ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571435ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571435ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571435ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571435ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571435ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571435ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571435ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571435ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571436ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571436ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571436ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571436ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571436ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571436ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571436ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571436ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571436ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571436ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571436ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571436ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571436ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571437ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571437ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571437ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571437ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571437ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571437ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571437ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571437ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571437ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571437ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571437ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571437ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571437ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571438ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571438ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571438ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571438ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571438ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571438ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571438ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571438ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571438ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571438ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571439ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571439ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571439ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571439ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571439ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571439ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571439ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571439ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571439ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571439ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571439ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571439ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571439ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571440ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571440ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571440ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571440ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571440ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571440ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571440ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571440ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571440ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571440ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571441ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571441ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571441ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571441ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571441ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571441ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571441ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571441ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571441ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571441ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571441ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571441ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571441ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571442ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571442ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571442ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571442ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571442ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571442ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571442ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571442ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571442ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571442ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571442ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571442ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571442ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571443ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571443ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571443ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571443ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571443ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571443ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571443ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571443ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571443ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571443ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571444ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571444ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571444ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571444ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571444ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571444ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571444ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571444ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571444ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571444ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571445ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571445ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571445ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571445ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571445ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571445ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571445ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571445ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571445ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571445ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571446ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571446ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571446ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571446ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571446ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571446ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571446ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571446ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571446ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571446ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571447ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571447ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571447ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571447ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571447ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571447ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571447ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571447ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571447ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571447ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571447ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571447ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571447ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571448ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571448ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571448ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571448ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571448ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571448ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571448ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571448ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571448ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571448ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571449ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571449ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571449ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571449ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571449ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571449ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571449ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571449ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571449ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571449ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571449ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571449ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571449ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571450ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571450ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571450ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571450ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571450ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571450ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571450ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571450ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571450ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571450ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571451ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571451ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571451ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571451ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571451ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571451ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571451ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571451ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571451ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571451ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571452ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571452ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571452ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571452ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571452ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571452ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571452ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571452ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571452ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571452ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571453ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571453ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571453ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571453ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571453ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571453ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571453ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571453ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571453ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571453ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571453ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571453ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1057 10571453ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571454ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571454ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571454ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571454ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571454ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1057 10571454ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571454ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1057 10571454ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1057 10571454ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1057 10571454ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661394ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661394ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661394ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1066 10661394ECSEQ1FDDTC Date of First Delay 2020-12-01 CRF C4591001ECC4591001 1066 10661394ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661394ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661394ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661394ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661394ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661394ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661394ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661394ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661394ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661394ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661395ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661395ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661395ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661395ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661395ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661395ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661395ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661395ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661395ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661395ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661397ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661397ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661397ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661397ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661397ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661397ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661397ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661397ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661397ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661397ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661397ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661397ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661397ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661401ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661401ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661401ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661401ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661401ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661401ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661401ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661401ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661401ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661401ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661401ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661401ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661401ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661402ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661402ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661402ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661402ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661402ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661402ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661402ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661402ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661402ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661402ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661403ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661403ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661403ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661403ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661403ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661403ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661403ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661403ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661403ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661403ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661403ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661403ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661403ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661404ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661404ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661404ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661404ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661404ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661404ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661404ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661404ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661404ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661404ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661405ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661405ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661405ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661405ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661405ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661405ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661405ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661405ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661405ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661405ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661405ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661405ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661405ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661407ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661407ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661407ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661407ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661407ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661407ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661407ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661407ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661407ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661407ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661408ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661408ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661408ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661408ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661408ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661408ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661408ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661408ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661408ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661408ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661409ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661409ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661409ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661409ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661409ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661409ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661409ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661409ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661409ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661409ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661410ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661410ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661410ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661410ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661410ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661410ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661410ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661410ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661410ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661410ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661410ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661410ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661410ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661411ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661411ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661411ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661411ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661411ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661411ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661411ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661411ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661411ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661411ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661412ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661412ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661412ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661412ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661412ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661412ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661412ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661412ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661412ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661412ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661412ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661412ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661412ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661415ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661415ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661415ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661415ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661415ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661415ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661415ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661415ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661415ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661415ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661415ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661415ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661415ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661416ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661416ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661416ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661416ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661416ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661416ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661416ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661416ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661416ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661416ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661416ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661416ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661416ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661417ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661417ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661417ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661417ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661417ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661417ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661417ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661417ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661417ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661417ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661418ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661418ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661418ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661418ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661418ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661418ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661418ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661418ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661418ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661418ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661418ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661418ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661418ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661419ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661419ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661419ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661419ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661419ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661419ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661419ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661419ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661419ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661419ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661420ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661420ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661420ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661420ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661420ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661420ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661420ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661420ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661420ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661420ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661421ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661421ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661421ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661421ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661421ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661421ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661421ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661421ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661421ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661421ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661421ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661421ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661421ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661422ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661422ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661422ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661422ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661422ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661422ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661422ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661422ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661422ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661422ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661423ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661423ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661423ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661423ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661423ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661423ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661423ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661423ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661423ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661423ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661423ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661423ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661423ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661424ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661424ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661424ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661424ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661424ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661424ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661424ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661424ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661424ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661424ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661425ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661425ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661425ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661425ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661425ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661425ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661425ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661425ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661425ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661425ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661425ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661425ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661425ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661426ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661426ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661426ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661426ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661426ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661426ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661426ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661426ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661426ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661426ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661426ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661426ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661426ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661427ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661427ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661427ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661427ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661427ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661427ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661427ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661427ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661427ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661427ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661428ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661428ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661428ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661428ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661428ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661428ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661428ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661429ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661429ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661429ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661429ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661429ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661429ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661429ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661429ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661429ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661429ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661429ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661429ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661429ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661430ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661430ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661430ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661430ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661430ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661430ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661430ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661430ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661430ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661430ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661431ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661431ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661431ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661431ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661431ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661431ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661431ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661431ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661431ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661431ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661432ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661432ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661432ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661432ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661432ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661432ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661432ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661432ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661432ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661432ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661432ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661432ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661432ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661433ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661433ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661433ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661433ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661433ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661433ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661433ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661433ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661433ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661433ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661433ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661433ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1066 10661433ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661434ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661434ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661434ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661434ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661434ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661434ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661434ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661434ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661434ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661434ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661435ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661435ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661435ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661435ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661435ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1066 10661435ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661435ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1066 10661435ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1066 10661435ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1066 10661435ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771275ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771275ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771275ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771275ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771275ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771275ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771275ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771277ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771277ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771277ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771277ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771277ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771277ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771277ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771279ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771280ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771280ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771280ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771280ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771280ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771280ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771280ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771281ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771281ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771281ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771281ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771281ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771281ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771281ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771281ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771281ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771281ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771283ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771283ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771283ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771283ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771283ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771283ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771283ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771285ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771285ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771285ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771285ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771285ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771285ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771285ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771287ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771287ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771287ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771290ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771294ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771294ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771294ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771294ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771294ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771294ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771294ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771295ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771295ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771295ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771295ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771295ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771295ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771295ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771298ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771298ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771298ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771298ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771298ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771298ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1077 10771298ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1077 10771300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1077 10771300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1077 10771300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1077 10771300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841541ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841541ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841541ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841541ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841541ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841541ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841541ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841541ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841541ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841541ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841542ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841542ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841542ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841542ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841542ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841542ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841542ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841542ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841542ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841542ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841543ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841543ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841543ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841543ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841543ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841543ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841543ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841543ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841543ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841543ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841543ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841543ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841543ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841544ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841544ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841544ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841544ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841544ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841544ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841544ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841544ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841544ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841544ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841545ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841545ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841545ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841545ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841545ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841545ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841545ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841545ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841545ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841545ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841545ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841545ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841545ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841546ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841546ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841546ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841546ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841546ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841546ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841546ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841546ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841546ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841546ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841547ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841547ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841547ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841547ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841547ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841547ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841547ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841547ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841547ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841547ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841547ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841547ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841547ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841548ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841548ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841548ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841548ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841548ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841548ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841548ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841548ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841548ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841548ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841549ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841549ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841549ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841549ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841549ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841549ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841549ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841549ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841549ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841549ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841550ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841550ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841550ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841550ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841550ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841550ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841550ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841550ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841550ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841550ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841550ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841550ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841550ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841551ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841551ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841551ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841551ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841551ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841551ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841551ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841551ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841551ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841551ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841552ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841552ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841552ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841552ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841552ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841552ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841552ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841552ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841552ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841552ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841552ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841552ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841552ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841553ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841553ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841553ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841553ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841553ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841553ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841553ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841553ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841553ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841553ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841555ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841555ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841555ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841555ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841555ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841555ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841555ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841555ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841555ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841555ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841555ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841555ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841555ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841556ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841556ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841556ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841556ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841556ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841556ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841556ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841556ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841556ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841556ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841557ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841557ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841557ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841557ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841557ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841557ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841557ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841557ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841557ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841557ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841558ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841558ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841558ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841558ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841558ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841558ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841558ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841558ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841558ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841558ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841559ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841559ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841559ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841559ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841559ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841559ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841559ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841559ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841559ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841559ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841560ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841560ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841560ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841560ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841560ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841560ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841560ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841560ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841560ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841560ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841560ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841560ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841560ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841561ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841561ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841561ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841561ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841561ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841561ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841561ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841561ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841561ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841561ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841561ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841561ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841561ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841562ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841562ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841562ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841562ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841562ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841562ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841562ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841562ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841562ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841562ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841563ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841563ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841563ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841563ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841563ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841563ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841563ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841563ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841563ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841563ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841564ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841564ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841564ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841564ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841564ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841564ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841564ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841564ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841564ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841564ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841564ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841564ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841564ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841565ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841565ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841565ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841565ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841565ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841565ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841565ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841565ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841565ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841565ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841565ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841565ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841565ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841566ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841566ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841566ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841566ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841566ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841566ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841566ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841566ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841566ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841566ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841567ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841567ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841567ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841567ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841567ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841567ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841567ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841567ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841567ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841567ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841568ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841568ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841568ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841568ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841568ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841568ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841568ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841568ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841568ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841568ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841569ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841569ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841569ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841569ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841569ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841569ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841569ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841569ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841569ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841569ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841569ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841569ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841569ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841570ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841570ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841570ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841570ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841570ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841570ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841570ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841570ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841570ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841570ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841570ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841570ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841570ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841571ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841571ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841571ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841571ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841571ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841571ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841571ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841571ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841571ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841571ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841571ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841571ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841571ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841572ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841572ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841572ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841572ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841572ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841572ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841572ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841572ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841572ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841572ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841572ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841572ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841572ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841573ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841573ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841573ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841573ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841573ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841573ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841573ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841573ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841573ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841573ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841574ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841574ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841574ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841574ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841574ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841574ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841574ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841574ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841574ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841574ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841575ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841575ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841575ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841575ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841575ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841575ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841575ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841575ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841575ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841575ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841575ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841575ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841575ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841576ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841576ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841576ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841576ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841576ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841576ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841576ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841576ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841576ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841576ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841577ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841577ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841577ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841577ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841577ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841577ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841577ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841577ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841577ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841577ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841577ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841577ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841577ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841578ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841578ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841578ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841578ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841578ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841578ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841578ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841578ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841578ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841578ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841579ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841579ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841579ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841579ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841579ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841579ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841579ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841579ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841579ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841579ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841580ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841580ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841580ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841580ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841580ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841580ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841580ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841580ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841580ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841580ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841581ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841581ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841581ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841581ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841581ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841581ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841581ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841581ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841581ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841581ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841581ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841581ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841581ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841582ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841582ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841582ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841582ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841582ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841582ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841582ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841582ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841582ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841582ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841583ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841583ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841583ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841583ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841583ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841583ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841583ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841583ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841583ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841583ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841584ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841584ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841584ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841584ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841584ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841584ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841584ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841584ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841584ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841584ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841586ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841586ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841586ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841586ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841586ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841586ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841586ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841586ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841586ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841586ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841586ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841586ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841586ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841587ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841587ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841587ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841587ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841587ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841587ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841587ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841587ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841587ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841587ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841587ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841587ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841587ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841588ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841588ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841588ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841588ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841588ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841588ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841588ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841588ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841588ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841588ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841588ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841588ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841588ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841589ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841589ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841589ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841589ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841589ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841589ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841589ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841589ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841589ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841589ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841590ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841590ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841590ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841590ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841590ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841590ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841590ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841590ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841590ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841590ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841590ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841590ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841590ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841591ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841591ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841591ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841591ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841591ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841591ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841591ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841591ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841591ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841591ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841592ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841592ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841592ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841592ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841592ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841592ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841592ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841592ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841592ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841592ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841593ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841593ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841593ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841593ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841593ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841593ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841593ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841593ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841593ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841593ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841594ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841594ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841594ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841594ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841594ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841594ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841594ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841594ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841594ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841594ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841595ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841595ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841595ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841595ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841595ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841595ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841595ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841595ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841595ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841595ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841595ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841595ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841595ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841596ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841596ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841596ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841596ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841596ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841596ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841596ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841596ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841596ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841596ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841596ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841596ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841596ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841597ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841597ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841597ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841597ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841597ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1084 10841597ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841597ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841597ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841597ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1084 10841597ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1084 10841597ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1084 10841597ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1084 10841597ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911394ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911394ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911394ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911394ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911394ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911394ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911394ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911394ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911394ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911394ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911395ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911395ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911395ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911395ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911395ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911395ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911395ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911395ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911395ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911395ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911396ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911396ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911396ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911396ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911396ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911396ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911396ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911396ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911396ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911396ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911396ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911396ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911396ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911399ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911399ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911399ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911399ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911399ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911399ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911399ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911399ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911399ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911399ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911400ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911400ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911400ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911400ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911400ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911400ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911400ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911400ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911400ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911400ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911400ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911400ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911400ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911402ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911402ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911402ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911402ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911402ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911402ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911402ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911402ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911402ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911402ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911403ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911403ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911403ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911403ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911403ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911403ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911403ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911403ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911403ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911403ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911404ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911404ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911404ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911404ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911404ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911404ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911404ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911404ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911404ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911404ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911405ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911405ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911405ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911405ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911405ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911405ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911405ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911405ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911405ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911405ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911405ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911405ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911405ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911406ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911406ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911406ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911406ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911406ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911406ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911406ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911406ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911406ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911406ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911407ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911407ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911407ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911407ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911407ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911407ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911407ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911407ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911407ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911407ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911407ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911407ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911407ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911408ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911408ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911408ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911408ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911408ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911408ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911408ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911408ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911408ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911408ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911409ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911409ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911409ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911409ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911409ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911409ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911409ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911409ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911409ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911409ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911410ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911410ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911410ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911410ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911410ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911410ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911410ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911410ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911410ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911410ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911411ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911411ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911411ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911411ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911411ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911411ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911411ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911411ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911411ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911411ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911411ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911411ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911411ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911412ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911412ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911412ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911412ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911412ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911412ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911412ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911412ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911412ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911412ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911413ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911413ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911413ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911413ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911413ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911413ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911413ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911413ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911413ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911413ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911415ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911415ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911415ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911415ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911415ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911415ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911415ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911415ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911415ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911415ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911415ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911415ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911415ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911416ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911416ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911416ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911416ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911416ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911416ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911416ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911416ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911416ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911416ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911417ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911417ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911417ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911417ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911417ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911417ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911417ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911417ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911417ECSEQ3ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1091 10911417ECSEQ3FDDTC Date of First Delay 2021-05-17 CRF C4591001ECC4591001 1091 10911417ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911417ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911417ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911417ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911418ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911418ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911418ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911418ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911418ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911418ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911418ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911418ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911418ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911418ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911418ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911418ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911418ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911419ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911419ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911419ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911419ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911419ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911419ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911419ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911419ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911419ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911419ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911420ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911420ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911420ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911420ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911420ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911420ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911420ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911420ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911420ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911420ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911421ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911421ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911421ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911421ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911421ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911421ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911421ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911421ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911421ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911421ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911421ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911421ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911421ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911422ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911422ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911422ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911422ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911422ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911422ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911422ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911422ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911422ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911422ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911423ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911423ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911423ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911423ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911423ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911423ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911423ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911423ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911423ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911423ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911423ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911423ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911423ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911424ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911424ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911424ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911424ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911424ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911424ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911424ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911424ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911424ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911424ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911424ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911424ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911424ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911425ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911425ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911425ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911425ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911425ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911425ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911425ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911425ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911425ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911425ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911425ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911425ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911425ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911426ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911426ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911426ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911426ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911426ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911426ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911426ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911426ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911426ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911426ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911427ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911427ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911427ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911427ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911427ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911427ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911427ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911427ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911427ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911427ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911429ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911429ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911429ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911429ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911429ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911429ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911429ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911429ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911429ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911429ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911429ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911429ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911429ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911430ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911430ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911430ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911430ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911430ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911430ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911430ECSEQ3ECCD Standardized Medication Code 88980201001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ3ECDECODStandardized Medication Name BNT162B2 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911430ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911430ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911430ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911430ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911430ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911430ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911431ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911431ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911431ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911431ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911431ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911431ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911431ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911431ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911431ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911431ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911432ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911432ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911432ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911432ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911432ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911432ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911432ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911432ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911432ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911432ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911433ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911433ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911433ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911433ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911433ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911433ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911433ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911433ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911433ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911433ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911434ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911434ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911434ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911434ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911434ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911434ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911434ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911434ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911434ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911434ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911434ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911434ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911434ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911435ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911435ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911435ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911435ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911435ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911435ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911435ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911435ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911435ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911435ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911436ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911436ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911436ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911436ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911436ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911436ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911436ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911436ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911436ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911436ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911437ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911437ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911437ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911437ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911437ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911437ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911437ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911437ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911437ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911437ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911437ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911437ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911437ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911438ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911438ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911438ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911438ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911438ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911438ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911438ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911438ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911438ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911438ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911439ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911439ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911439ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911439ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911439ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911439ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911439ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911439ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911439ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911439ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911439ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911439ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911439ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911440ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911440ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911440ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911440ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911440ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911440ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911440ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911440ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911440ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911440ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911441ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911441ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911441ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911441ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911441ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911441ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911441ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911441ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911441ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911441ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911441ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911441ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911441ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911442ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911442ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911442ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911442ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911442ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911442ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911442ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911442ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911442ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911442ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911442ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911442ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911442ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911443ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911443ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911443ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911443ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911443ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911443ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911443ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911443ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911443ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911443ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911444ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911444ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911444ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911444ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911444ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911444ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911444ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911444ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911444ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911444ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911445ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911445ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911445ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911445ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911445ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911445ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911445ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911445ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911445ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911445ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911445ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911445ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911445ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911446ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911446ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911446ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911446ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911446ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911446ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911446ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911446ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911446ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911446ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911447ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911447ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911447ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911447ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911447ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911447ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911447ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911447ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911447ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911447ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911448ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911448ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911448ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911448ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911448ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911448ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911448ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911448ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911448ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911448ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911448ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911448ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911448ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911449ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911449ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911449ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911449ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911449ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911449ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911449ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911449ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911449ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911449ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911450ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911450ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911450ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911450ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911450ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911450ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911450ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911450ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911450ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911450ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911450ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911450ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911450ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911452ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911452ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911452ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911452ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911452ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911452ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911452ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911452ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911452ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911452ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911452ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911452ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911452ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911453ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911453ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911453ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911453ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911453ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911453ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911453ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911453ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911453ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911453ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911454ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911454ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911454ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911454ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911454ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911454ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911454ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911454ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911454ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911454ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911455ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911455ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911455ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911455ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911455ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911455ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911455ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911455ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911455ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911455ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911456ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911456ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911456ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911456ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911456ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911456ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911456ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911456ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911456ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911456ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911457ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911457ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911457ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911457ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911457ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911457ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911457ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911457ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911457ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911457ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911458ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911458ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911458ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911458ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911458ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911458ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911458ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911458ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911458ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911458ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911459ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911459ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911459ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911459ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911459ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911459ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911459ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911459ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911459ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911459ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911459ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911459ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911459ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911460ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911460ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911460ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911460ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911460ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911460ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911460ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911460ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911460ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911460ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911461ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911461ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911461ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911461ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911461ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911461ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911461ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911461ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911461ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911461ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911462ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911462ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911462ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911462ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911462ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911462ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911462ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911462ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911462ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911462ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911463ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911463ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911463ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911463ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911463ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911463ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911463ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911463ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911463ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911463ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911463ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911463ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911463ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911464ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911464ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911464ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911464ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911464ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911464ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911464ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911464ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911464ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911464ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911465ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911465ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911465ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911465ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911465ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911465ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911465ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911465ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911465ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911465ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911466ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911466ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911466ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911466ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911466ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1091 10911466ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911466ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911466ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911466ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1091 10911466ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1091 10911466ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1091 10911466ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1091 10911466ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231422ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231422ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231422ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231422ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231422ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231422ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231422ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231422ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231422ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231422ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231425ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231425ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231425ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231425ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231425ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231425ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231425ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231425ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231425ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231425ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231431ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231431ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231431ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231431ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231431ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231431ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231431ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231431ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231431ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231431ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231431ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231431ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231431ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231432ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231432ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231432ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231432ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231432ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231432ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231432ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231432ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231432ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231432ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231434ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231434ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231434ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231434ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231434ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231434ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231434ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231434ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231434ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231434ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231438ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231438ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231438ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231438ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231438ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231438ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231438ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231438ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231438ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231438ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231439ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231439ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231439ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231439ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231439ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231439ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231439ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231439ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231439ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231439ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231440ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231440ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231440ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231440ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231440ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231440ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231440ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231440ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231440ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231440ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231441ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231441ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231441ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231441ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231441ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231441ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231441ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231441ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231441ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231441ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231442ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231442ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231442ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231442ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231442ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231442ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231442ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231442ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231442ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231442ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231442ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231442ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231442ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231443ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231443ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231443ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231443ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231443ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231443ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231443ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231443ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231443ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231443ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231445ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231445ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231445ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231445ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231445ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231445ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231445ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231445ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231445ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231445ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231446ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231446ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231446ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231446ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231446ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231446ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231446ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231446ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231446ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231446ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231447ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231447ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231447ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231447ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231447ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231447ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231447ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231447ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231447ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231447ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231448ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231448ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231448ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231448ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231448ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231448ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231448ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231448ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231448ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231448ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231449ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231449ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231449ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231449ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231449ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231449ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231449ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231449ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231449ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231449ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231450ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231450ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231450ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231450ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231450ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231450ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231450ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231450ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231450ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231450ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231450ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231450ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231450ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231451ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231451ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231451ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231451ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231451ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231451ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231451ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231451ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231451ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231451ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231452ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231452ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231452ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231452ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231452ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231452ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231452ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231452ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231452ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231452ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231452ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231452ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231452ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231453ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231453ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231453ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231453ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231453ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231453ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231453ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231453ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231453ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231453ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231454ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231454ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231454ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231454ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231454ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231454ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231454ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231454ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231454ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231454ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231454ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231454ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231454ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231455ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231455ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231455ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231455ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231455ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231455ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231455ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231455ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231455ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231455ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231456ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231456ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231456ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231456ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231456ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231456ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231456ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231456ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231456ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231456ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231456ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231456ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231456ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231457ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231457ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231457ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231457ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231457ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231457ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231457ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231457ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231457ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231457ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231457ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231457ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231457ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231458ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231458ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231458ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231458ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231458ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231458ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231458ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231458ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231458ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231458ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231459ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231459ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231459ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231459ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231459ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231459ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231459ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231459ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231459ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231459ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231460ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231460ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231460ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231460ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231460ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231460ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231460ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231460ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231460ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231460ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231460ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231460ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231460ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231461ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231461ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231461ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231461ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231461ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231461ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231461ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231461ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231461ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231461ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231462ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231462ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231462ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231462ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231462ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231462ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231462ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231462ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231462ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231462ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231463ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231463ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231463ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231463ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231463ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231463ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231463ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231463ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231463ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231463ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231463ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231463ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231463ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231465ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231465ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231465ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231465ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231465ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231465ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231465ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231465ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231465ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231465ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231465ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231465ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231465ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231466ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231466ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231466ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231466ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231466ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231466ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231466ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231466ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231466ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231466ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231467ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231467ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231467ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231467ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231467ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231467ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231467ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231467ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231467ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231467ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231467ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231467ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231467ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231468ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231468ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231468ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231468ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231468ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231468ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231468ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231468ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231468ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231468ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231468ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231468ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231468ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231469ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231469ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231469ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231469ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231469ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231469ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231469ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231469ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231469ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231469ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231470ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231470ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231470ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231470ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231470ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231470ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231470ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231470ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231470ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231470ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231470ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231470ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231470ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231472ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231472ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231472ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231472ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231472ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231472ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231472ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231472ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231472ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231472ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231473ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231473ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231473ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231473ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231473ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231473ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231473ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231473ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231473ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231473ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231473ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231473ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231473ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231474ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231474ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231474ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231474ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231474ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231474ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231474ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231474ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231474ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231474ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231475ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231475ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231475ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231475ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231475ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231475ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231475ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231475ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231475ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231475ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231476ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231476ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231476ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231476ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231476ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231476ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231476ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231476ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231476ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231476ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231476ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231476ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231476ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231477ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231477ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231477ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231477ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231477ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231477ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231477ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231477ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231477ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231477ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231478ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231478ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231478ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231478ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231478ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231478ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231478ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231478ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231478ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231478ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231479ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231479ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231479ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231479ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231479ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231479ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231479ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231479ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231479ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231479ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231481ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231481ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231481ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231481ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231481ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231481ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231481ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231481ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231481ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231481ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231482ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231482ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231482ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231482ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231482ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231482ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231482ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231482ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231482ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231482ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231483ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231483ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231483ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231483ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231483ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231483ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231483ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231483ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231483ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231483ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231484ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231484ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231484ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231484ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231484ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231484ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231484ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231484ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231484ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231484ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231485ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231485ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231485ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231485ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231485ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231485ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231485ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231485ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231485ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231485ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231485ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231485ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231485ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231486ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231486ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231486ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231486ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231486ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231486ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231486ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231486ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231486ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231486ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231487ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231487ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231487ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231487ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231487ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231487ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231487ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231487ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231487ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231487ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231487ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231487ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231487ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231488ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231488ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231488ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231488ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231488ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231488ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231488ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231488ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231488ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231488ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231489ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231489ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231489ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231489ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231489ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231489ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231489ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231489ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231489ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231489ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231491ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231491ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231491ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231491ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231491ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231491ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231491ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231491ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231491ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231491ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231492ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231492ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231492ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231492ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231492ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231492ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231492ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231492ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231492ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231492ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231492ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231492ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231492ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231493ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231493ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231493ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231493ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231493ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231493ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231493ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231493ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231493ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231493ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231494ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231494ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231494ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231494ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231494ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231494ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231494ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231494ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231494ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231494ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231495ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231495ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231495ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231495ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231495ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231495ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231495ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231495ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231495ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231495ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231496ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231496ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231496ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231496ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231496ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231496ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231496ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231496ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231496ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231496ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231496ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231496ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231496ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231497ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231497ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231497ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231497ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231497ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231497ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231497ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231497ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231497ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231497ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231497ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231497ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231497ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231499ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231499ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231499ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231499ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231499ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231499ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231499ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231499ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231499ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231499ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231499ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231499ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231499ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231500ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231500ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231500ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231500ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231500ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231500ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231500ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231500ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231500ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231500ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231501ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231501ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231501ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231501ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231501ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231501ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231501ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231501ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231501ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231501ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231501ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231501ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231501ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231502ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231502ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231502ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231502ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231502ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231502ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231502ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231502ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231502ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231502ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231503ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231503ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231503ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231503ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231503ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231503ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231503ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231503ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231503ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231503ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231503ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231503ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231503ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231504ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231504ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231504ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231504ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231504ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231504ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231504ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231504ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231504ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231504ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231505ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231505ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231505ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231505ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231505ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231505ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231505ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231505ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231505ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231505ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231505ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231505ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231505ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231506ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231506ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231506ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231506ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231506ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231506ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231506ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231506ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231506ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231506ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231507ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231507ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231507ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231507ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231507ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231507ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231507ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231507ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231507ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231507ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231508ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231508ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231508ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231508ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231508ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231508ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231508ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231508ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231508ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231508ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231509ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231509ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231509ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231509ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231509ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231509ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231509ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231509ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231509ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231509ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231509ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231509ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231509ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231510ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231510ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231510ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231510ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231510ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231510ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231510ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231510ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231510ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231510ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231510ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231510ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231510ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231511ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231511ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231511ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231511ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231511ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231511ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231511ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231511ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231511ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231511ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231512ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231512ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231512ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231512ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231512ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231512ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231512ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231512ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231512ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231512ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231513ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231513ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231513ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231513ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231513ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231513ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231513ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231513ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231513ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231513ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231513ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231513ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231513ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231514ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231514ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231514ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231514ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231514ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231514ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231514ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231514ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231514ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231514ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231514ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231514ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231514ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231515ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231515ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231515ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231515ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231515ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231515ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231515ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231515ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231515ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231515ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231516ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231516ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231516ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231516ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231516ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231516ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231516ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231516ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231516ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231516ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231516ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231516ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231516ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231517ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231517ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231517ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231517ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231517ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231517ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231517ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231517ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231517ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231517ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231518ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231518ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231518ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231518ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231518ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231518ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231518ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231518ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231518ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231518ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231519ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231519ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231519ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231519ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231519ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231519ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231519ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231519ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231519ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231519ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231520ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231520ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231520ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231520ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231520ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231520ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231520ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231520ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231520ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231520ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231520ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231520ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231520ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231521ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231521ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231521ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231521ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231521ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231521ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231521ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231521ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231521ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231521ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231522ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231522ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231522ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231522ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231522ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231522ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231522ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231522ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231522ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231522ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231522ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231522ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231522ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231523ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231523ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231523ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231523ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231523ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231523ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231523ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231523ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231523ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231523ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231523ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231523ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231523ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231524ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231524ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231524ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231524ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231524ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231524ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231524ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231524ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231524ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231524ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231525ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231525ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231525ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231525ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231525ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231525ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231525ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231525ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231525ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231525ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231526ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231526ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231526ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231526ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231526ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231526ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231526ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231526ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231526ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1123 11231526ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1123 11231526ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231526ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1123 11231526ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1123 11231526ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1123 11231526ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241236ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241236ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241236ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241236ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241236ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241236ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241236ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241236ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241236ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241236ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241238ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241238ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241238ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241238ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241238ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241238ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241238ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241238ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241238ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241238ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241239ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241239ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241239ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241239ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241239ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241239ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241239ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241239ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241239ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241239ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241240ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241240ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241240ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241240ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241240ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241240ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241240ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241240ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241240ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241240ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241240ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241240ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241240ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241241ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241241ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241241ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241241ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241241ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241241ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241241ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241241ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241241ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241241ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241241ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241241ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241241ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241242ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241242ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241242ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241242ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241242ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241242ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241242ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241242ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241242ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241242ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241243ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241243ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241243ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241243ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241243ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241243ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241243ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241243ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241243ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241243ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241244ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241244ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241244ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241244ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241244ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241244ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241244ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241244ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241244ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241244ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241245ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241245ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241245ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241245ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241245ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241245ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241245ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241245ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241245ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241245ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241246ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241246ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241246ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241246ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241246ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241246ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241246ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241246ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241246ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241246ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241247ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241247ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241247ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241247ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241247ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241247ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241247ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241247ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241247ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241247ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241247ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241247ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241247ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241248ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241248ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241248ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241248ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241248ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241248ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241248ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241248ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241248ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241248ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241248ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241248ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241248ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241249ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241249ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241249ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241249ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241249ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241249ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241249ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241249ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241249ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241249ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241250ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241250ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241250ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241250ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241250ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241250ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241250ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241251ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241251ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241251ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241251ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241251ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241251ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241251ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241251ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241251ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241251ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241252ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241252ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241252ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241252ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241252ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241252ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241252ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241252ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241252ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241252ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241252ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241252ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241252ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241254ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241254ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241254ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241254ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241254ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241254ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241254ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241254ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241254ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241254ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241255ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241255ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241255ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241255ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241255ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241255ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241255ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241255ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241255ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241255ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241255ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241255ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241255ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241256ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241256ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241256ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241256ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241256ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241256ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241256ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241256ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241256ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241256ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241257ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241257ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241257ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241257ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241257ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241257ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241257ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241257ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241257ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241257ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241257ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241257ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241257ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241258ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241258ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241258ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241258ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241258ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241258ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241258ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241258ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241258ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241258ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241258ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241258ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241258ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241259ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241259ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241259ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241259ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241259ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241259ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241259ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241259ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241259ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241259ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241260ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241260ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241260ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241260ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241260ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241260ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241260ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241260ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241260ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241260ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241261ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241261ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241261ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241261ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241261ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241261ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241261ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241261ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241261ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241261ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241262ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241262ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241262ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241262ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241262ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241262ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241262ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241262ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241262ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241262ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241263ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241263ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241263ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241263ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241263ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241263ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241263ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241264ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241264ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241264ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241264ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241264ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241264ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241264ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241264ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241264ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241264ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241264ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241264ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241264ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241265ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241265ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241265ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241265ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241265ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241265ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241265ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241265ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241265ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241265ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241266ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241266ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241266ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241266ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241266ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241266ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241266ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241266ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241266ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241266ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241267ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241267ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241267ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241267ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241267ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241267ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241267ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241267ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241267ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241267ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241267ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241267ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241267ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241268ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241268ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241268ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241268ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241268ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241268ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241268ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241268ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241268ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241268ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241268ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241268ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241268ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241269ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241269ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241269ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241269ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241269ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241269ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241269ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241269ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241269ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241269ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241270ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241270ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241270ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241270ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241270ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241270ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241270ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241271ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241271ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241271ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241271ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241271ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241271ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241271ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241271ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241271ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241271ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241272ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241272ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241272ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241272ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241272ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241272ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241272ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241272ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241272ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241272ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241272ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241272ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241272ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241274ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241274ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241274ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241274ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241274ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241274ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1124 11241274ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1124 11241275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1124 11241275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1124 11241275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1124 11241275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251241ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251241ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251241ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251241ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251241ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251241ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251241ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251241ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251241ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251241ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251242ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251242ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251242ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251242ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251242ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251242ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251242ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251242ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251242ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251242ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251242ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251242ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251242ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251244ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251244ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251244ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251244ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251244ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251244ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251244ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251244ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251244ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251244ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251244ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251244ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251244ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251246ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251246ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251246ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251246ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251246ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251246ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251246ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251246ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251246ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251246ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251248ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251248ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251248ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251248ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251248ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251248ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251248ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251248ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251248ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251248ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251249ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251249ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251249ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251249ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251249ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251249ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251249ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251249ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251249ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251249ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251249ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251249ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251249ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251251ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251251ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251251ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251251ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251251ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251251ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251251ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251251ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251251ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251251ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251252ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251252ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251252ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251252ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251252ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251252ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251252ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251252ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251252ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251252ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251253ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251253ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251253ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251253ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251253ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251253ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251253ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251254ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251254ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251254ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251254ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251254ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251254ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251254ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251254ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251254ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251254ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251254ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251254ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1125 11251254ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251255ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251255ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251255ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251255ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251255ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1125 11251255ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251255ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1125 11251255ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1125 11251255ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1125 11251255ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261229ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261229ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261229ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261229ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261229ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261229ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261229ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261229ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261229ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261229ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261230ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261230ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261230ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261230ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261230ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261230ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261230ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261230ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261230ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261230ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261233ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261233ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261233ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261233ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261233ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261233ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261233ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261233ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261233ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261233ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261233ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261233ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261233ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261235ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261235ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261235ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261235ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261235ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261235ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261235ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261235ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261235ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261235ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261235ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261235ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261235ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261239ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261239ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261239ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261239ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261239ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261239ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261239ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261239ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261239ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261239ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261239ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261239ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261239ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261240ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261240ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261240ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261240ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261240ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261240ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261240ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261240ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261240ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261240ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261240ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261240ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261240ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261241ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261241ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261241ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261241ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261241ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261241ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261241ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261241ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261241ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261241ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261243ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261243ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261243ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261243ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261243ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261243ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261243ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261243ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261243ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261243ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261246ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261246ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261246ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261246ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261246ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261246ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261246ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261246ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261246ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261246ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261249ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261249ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261249ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261249ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261249ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261249ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261249ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261249ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261249ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261249ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261250ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261250ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261250ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261250ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261250ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261250ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261250ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261253ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261253ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261253ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261253ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261253ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261253ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261253ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261254ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261254ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261254ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261254ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261254ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261254ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261254ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261254ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261254ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261254ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261254ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261254ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261254ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261255ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261255ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261255ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261255ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261255ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261255ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261255ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261255ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261255ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261255ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261258ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261258ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261258ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261258ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261258ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261258ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261258ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261258ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261258ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261258ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261262ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261262ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261262ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261262ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261262ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261262ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261262ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261262ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261262ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261262ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261262ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261262ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261262ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261264ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261264ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261264ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261264ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261264ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261264ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261264ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261264ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261264ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261264ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261265ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261265ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261265ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261265ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261265ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261265ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261265ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261265ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261265ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261265ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261265ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261265ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261265ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261266ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261266ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261266ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261266ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261266ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261266ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261266ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261266ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261266ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261266ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261266ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261266ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261266ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261267ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261267ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261267ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261267ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261267ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261267ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261267ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261267ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261267ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261267ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261267ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261267ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261267ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261268ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261268ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261268ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261268ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261268ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261268ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261268ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261268ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261268ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261268ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261269ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261269ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261269ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261269ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261269ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261269ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261269ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261269ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261269ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261269ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261270ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261270ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261270ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261270ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261270ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261270ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261270ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261271ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261271ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261271ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261271ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261271ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261271ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261271ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261271ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261271ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261271ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261274ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261274ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261274ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261274ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261274ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261274ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261274ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261275ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261275ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261275ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261275ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261275ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261275ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261275ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261276ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261276ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261276ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261276ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261276ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261276ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261276ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261276ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261276ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261276ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261276ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261276ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261276ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261279ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261279ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261279ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261279ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261279ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261279ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261279ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261279ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261280ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261280ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261280ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261280ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261280ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261280ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261280ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261281ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261281ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261281ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261281ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261281ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261281ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261281ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261281ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261281ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261281ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261283ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261283ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261283ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261283ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261283ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261283ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261283ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261284ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261284ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261284ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261284ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261284ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261284ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261284ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261287ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261287ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261287ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261287ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261287ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261287ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261287ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261287ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261289ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261289ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261289ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261289ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261289ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261289ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261289ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261290ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261290ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261290ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261290ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261290ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261290ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261290ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261290ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261292ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261292ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261292ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261292ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261293ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261293ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261293ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261293ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261293ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261293ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261293ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261293ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261293ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261293ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261294ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261294ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261294ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261294ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261294ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261294ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261294ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261296ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261296ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261296ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261296ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261296ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261296ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261296ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261297ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261297ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261297ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261297ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261297ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261297ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261297ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261300ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261300ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261300ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261300ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261300ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261300ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261300ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261301ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261301ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261301ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261301ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261301ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261301ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261301ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261301ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261301ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261301ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261302ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261302ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261302ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261302ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261302ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261302ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261302ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261302ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261302ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261302ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261302ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261302ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261302ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261303ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261303ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261303ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261303ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261303ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261303ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261303ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261303ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261303ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261303ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261304ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261304ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261304ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261304ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261304ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261304ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261304ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261304ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261304ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261304ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261305ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261305ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261305ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261305ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261305ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261305ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261305ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261305ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261305ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261305ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261305ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261305ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261305ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261306ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261306ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261306ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261306ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261306ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261306ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261306ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261306ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261306ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261306ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261306ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261306ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261306ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261307ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261307ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261307ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261307ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261307ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261307ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261307ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261307ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261307ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261307ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261308ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261308ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261308ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261308ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261308ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261308ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261308ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261308ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261308ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261308ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261308ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261308ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261308ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261309ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261309ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261309ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261309ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261309ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261309ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261309ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261309ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261309ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261309ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261310ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261310ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261310ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261310ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261310ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261310ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261310ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261310ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261310ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261310ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261311ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261311ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261311ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261311ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261311ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261311ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261311ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261311ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261311ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261311ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261311ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261311ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261311ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261312ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261312ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261312ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261312ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261312ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261312ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261312ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261312ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261312ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261312ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261312ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261312ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261312ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261313ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261313ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261313ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261313ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261313ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261313ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261313ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261313ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261313ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261313ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261314ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261314ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261314ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261314ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261314ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261314ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261314ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261314ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261314ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261314ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261314ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261314ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261314ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261315ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261315ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261315ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261315ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261315ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261315ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261315ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261315ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261315ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261315ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261316ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261316ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261316ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261316ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261316ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261316ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261316ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261316ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261316ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261316ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261317ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261317ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261317ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261317ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261317ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261317ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261317ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261317ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261317ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261317ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261317ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261317ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261317ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261318ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261318ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261318ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261318ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261318ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261318ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261318ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261318ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261318ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261318ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261318ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261318ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261318ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261319ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261319ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261319ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261319ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261319ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261319ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261319ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261319ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261319ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261319ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261320ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261320ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261320ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261320ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261320ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261320ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261320ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261320ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261320ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261320ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261320ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261320ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261320ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261321ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261321ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261321ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261321ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261321ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261321ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261321ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261321ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261321ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261321ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261322ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261322ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261322ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261322ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261322ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261322ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261322ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261322ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261322ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261322ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261322ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261322ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261322ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1126 11261325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261325ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261325ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261325ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1126 11261325ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1126 11261325ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1126 11261325ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1126 11261325ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311279ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1131 11311279ECSEQ1FDDTC Date of First Delay 2020-12-17 CRF C4591001ECC4591001 1131 11311279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311280ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311280ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311280ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311280ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311280ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311280ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311280ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311281ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311281ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311281ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311281ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311281ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311281ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311281ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311281ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311281ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311281ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311283ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311283ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311283ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311283ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311283ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311283ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311283ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311285ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311285ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311285ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311285ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311285ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311285ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311285ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311287ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311287ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311287ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311287ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311287ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311287ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311287ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311287ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311287ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311288ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311288ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311288ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311288ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311288ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311288ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311288ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311290ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311292ECSEQ2ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1131 11311292ECSEQ2FDDTC Date of First Delay 2021-01-25 CRF C4591001ECC4591001 1131 11311292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311293ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311293ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311293ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311293ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311293ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311293ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311293ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311293ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311293ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311293ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311293ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311293ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311293ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311295ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311295ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311295ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311295ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311295ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311295ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311295ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311296ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311296ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311296ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311296ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311296ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311296ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311296ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311299ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311299ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311299ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311299ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311299ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311299ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311299ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311300ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311300ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311300ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311300ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311300ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311300ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1131 11311300ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311301ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311301ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311301ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311301ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311301ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311301ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311301ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311301ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311301ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311301ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311302ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311302ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311302ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311302ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311302ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1131 11311302ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311302ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1131 11311302ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1131 11311302ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1131 11311302ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391144ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391144ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391144ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391144ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391144ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391144ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391144ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391144ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391144ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391144ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391145ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391145ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391145ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391145ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391145ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391145ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391145ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391145ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391145ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391145ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391151ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391151ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391151ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391151ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391151ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391151ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391151ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391151ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391151ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391151ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391152ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391152ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391152ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391152ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391152ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391152ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391152ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391152ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391152ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391152ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391152ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391152ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391152ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391154ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391154ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391154ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391154ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391154ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391154ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391154ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391154ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391154ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391154ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391154ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391154ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391154ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391155ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391155ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391155ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391155ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391155ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391155ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391155ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391155ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391155ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391155ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391156ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391156ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391156ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391156ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391156ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391156ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391156ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391156ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391156ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391156ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391157ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391157ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391157ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391157ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391157ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391157ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391157ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391157ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391157ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391157ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391157ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391157ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391157ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391158ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391158ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391158ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391158ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391158ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391158ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391158ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391158ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391158ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391158ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391158ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391158ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391158ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391159ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391159ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391159ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391159ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391159ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391159ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391159ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391159ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391159ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391159ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391159ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391159ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391159ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391161ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391161ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391161ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391161ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391161ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391161ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391161ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391161ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391161ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391161ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391162ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391162ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391162ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391162ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391162ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391162ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391162ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391162ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391162ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391162ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391163ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391163ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391163ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391163ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391163ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391163ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391163ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391163ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391163ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391163ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391163ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391163ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391163ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391165ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391165ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391165ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391165ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391165ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391165ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391165ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391165ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391165ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391165ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391166ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391166ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391166ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391166ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391166ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391166ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391166ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391166ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391166ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391166ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391166ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391166ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391166ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391168ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391168ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391168ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391168ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391168ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391168ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391168ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391168ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391168ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391168ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391168ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391168ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391168ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391169ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391169ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391169ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391169ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391169ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391169ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391169ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391169ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391169ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391169ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391170ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391170ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391170ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391170ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391170ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391170ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391170ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391170ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391170ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391170ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391171ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391171ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391171ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391171ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391171ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391171ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391171ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391171ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391171ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391171ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391172ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391172ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391172ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391172ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391172ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391172ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391172ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391172ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391172ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391172ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391173ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391173ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391173ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391173ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391173ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391173ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391173ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391173ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391173ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391173ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391174ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391174ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391174ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391174ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391174ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391174ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391174ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391174ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391174ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391174ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391174ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391174ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391174ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391175ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391175ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391175ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391175ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391175ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391175ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391175ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391175ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391175ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391175ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391175ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391175ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391175ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391177ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391177ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391177ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391177ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391177ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391177ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391177ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391177ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391177ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391177ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391178ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391178ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391178ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391178ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391178ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391178ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391178ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391178ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391178ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391178ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391179ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391179ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391179ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391179ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391179ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391179ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391179ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391179ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391179ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391179ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391180ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391180ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391180ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391180ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391180ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391180ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391180ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391180ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391180ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391180ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391180ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391180ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391180ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391181ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391181ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391181ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391181ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391181ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391181ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391181ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391181ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391181ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391181ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391181ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391181ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391181ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391182ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391182ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391182ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391182ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391182ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391182ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391182ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391182ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391182ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391182ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391182ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391182ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391182ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391183ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391183ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391183ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391183ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391183ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391183ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391183ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391183ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391183ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391183ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391185ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391185ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391185ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391185ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391185ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391185ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391185ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391185ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391185ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391185ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391185ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391185ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391185ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391186ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391186ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391186ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391186ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391186ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391186ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391186ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391186ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391186ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391186ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391187ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391187ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391187ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391187ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391187ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391187ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391187ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391187ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391187ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391187ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391187ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391187ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391187ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391188ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391188ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391188ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391188ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391188ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391188ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391188ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391188ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391188ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391188ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391189ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391189ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391189ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391189ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391189ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391189ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391189ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391189ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391189ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391189ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391190ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391190ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391190ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391190ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391190ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391190ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391190ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391190ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391190ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391190ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391191ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391191ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391191ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391191ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391191ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391191ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391191ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391191ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391191ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391191ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391192ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391192ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391192ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391192ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391192ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391192ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391192ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391192ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391192ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391192ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391193ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391193ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391193ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391193ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391193ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391193ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391193ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391193ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391193ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391193ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391193ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391193ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391193ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391195ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391195ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391195ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391195ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391195ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391195ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391195ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391195ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391195ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391195ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391195ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391195ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391195ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391196ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391196ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391196ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391196ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391196ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391196ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391196ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391196ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391196ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391196ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391196ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391196ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391196ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391197ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391197ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391197ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391197ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391197ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391197ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391197ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391197ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391197ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391197ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391198ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391198ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391198ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391198ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391198ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391198ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391198ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391198ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391198ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391198ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391198ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391198ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391198ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391199ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391199ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391199ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391199ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391199ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391199ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391199ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391199ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391199ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391199ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391200ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391200ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391200ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391200ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391200ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391200ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391200ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391200ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391200ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391200ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391201ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391201ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391201ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391201ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391201ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391201ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391201ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391201ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391201ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391201ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391202ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391202ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391202ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391202ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391202ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391202ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391202ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391202ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391202ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391202ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391202ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391202ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391202ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391203ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391203ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391203ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391203ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391203ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391203ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391203ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391203ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391203ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391203ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391203ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391203ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391203ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391203ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391203ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391204ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391204ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391204ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391204ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391204ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391204ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391204ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391204ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391204ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391204ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391205ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391205ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391205ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391205ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391205ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391205ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391205ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391205ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391205ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391205ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391205ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391205ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391205ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391206ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391206ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391206ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391206ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391206ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391206ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391206ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391206ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391206ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391206ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391207ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391207ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391207ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391207ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391207ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391207ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391207ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391207ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391207ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391207ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391207ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391207ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391207ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391208ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391208ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391208ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391208ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391208ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391208ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391208ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391208ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391208ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391208ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391208ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391208ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391208ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391209ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391209ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391209ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391209ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391209ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391209ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391209ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391209ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391209ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391209ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391210ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391210ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391210ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391210ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391210ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391210ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391210ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391210ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391210ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391210ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391210ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391210ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391210ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391211ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391211ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391211ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391211ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391211ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391211ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391211ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391211ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391211ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391211ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391212ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391212ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391212ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391212ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391212ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391212ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391212ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391212ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391212ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391212ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391212ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391212ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391212ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391213ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391213ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391213ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391213ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391213ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391213ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391213ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391213ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391213ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391213ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391214ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391214ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391214ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391214ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391214ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391214ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391214ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391214ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391214ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391214ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391215ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391215ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391215ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391215ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391215ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391215ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391215ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391215ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391215ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391215ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391215ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391215ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391215ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391216ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391216ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391216ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391216ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391216ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391216ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391216ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391216ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391216ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391216ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391217ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391217ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391217ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391217ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391217ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391217ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391217ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391217ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391217ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391217ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391217ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391217ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391217ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391218ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391218ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391218ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391218ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391218ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391218ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391218ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391218ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391218ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391218ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391219ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391219ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391219ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391219ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391219ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391219ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391219ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391219ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391219ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391219ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391219ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391219ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391219ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391220ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391220ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391220ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391220ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391220ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391220ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391220ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391220ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391220ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391220ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391220ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391220ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391220ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391221ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391221ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391221ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391221ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391221ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391221ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391221ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391221ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391221ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391221ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391222ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391222ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391222ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391222ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391222ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391222ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391222ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391222ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391222ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391222ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391222ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391222ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391222ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391223ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391223ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391223ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391223ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391223ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391223ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391223ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391223ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391223ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391223ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391224ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391224ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391224ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391224ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391224ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391224ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391224ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391224ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391224ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391224ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391224ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391224ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391224ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391225ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391225ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391225ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391225ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391225ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391225ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391225ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391225ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391225ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391225ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391226ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391226ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391226ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391226ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391226ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391226ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391226ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391226ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391226ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391226ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391227ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391227ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391227ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391227ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391227ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391227ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391227ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391227ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391227ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391227ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391227ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391227ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391227ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391228ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391228ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391228ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391228ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391228ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391228ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391228ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391228ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391228ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391228ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391228ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391228ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391228ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391229ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391229ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391229ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391229ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391229ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391229ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391229ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391229ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391229ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391229ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391229ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391229ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391229ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391230ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391230ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391230ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391230ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391230ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391230ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391230ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391230ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391230ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391230ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391231ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391231ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391231ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391231ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391231ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391231ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391231ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391231ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391231ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391231ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391232ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391232ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391232ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391232ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391232ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391232ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391232ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391232ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391232ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391232ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391233ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391233ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391233ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391233ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391233ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391233ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391233ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391233ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391233ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391233ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391235ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391235ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391235ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391235ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391235ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391235ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391235ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391235ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391235ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391235ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391235ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391235ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391235ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391236ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391236ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391236ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391236ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391236ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391236ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391236ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391236ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391236ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391236ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391237ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391237ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391237ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391237ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391237ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391237ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391237ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391237ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391237ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391237ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391237ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391237ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391237ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391238ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391238ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391238ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391238ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391238ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391238ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391238ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391238ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391238ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391238ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391239ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391239ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391239ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391239ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391239ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391239ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391239ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391239ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391239ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391239ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391239ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391239ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391239ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391240ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391240ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391240ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391240ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391240ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391240ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391240ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391240ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391240ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391240ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391241ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391241ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391241ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391241ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391241ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391241ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391241ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391241ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391241ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391241ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391241ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391241ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391241ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391242ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391242ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391242ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391242ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391242ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391242ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391242ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391242ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391242ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391242ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391243ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391243ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391243ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391243ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391243ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391243ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391243ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391243ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391243ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391243ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391243ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391243ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391243ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391244ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391244ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391244ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391244ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391244ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391244ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391244ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391244ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391244ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391244ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391245ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391245ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391245ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391245ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391245ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391245ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391245ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391245ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391245ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391245ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391246ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391246ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391246ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391246ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391246ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391246ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391246ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391246ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391246ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391246ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391246ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391246ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391246ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391247ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391247ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391247ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391247ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391247ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391247ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391247ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391247ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391247ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391247ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391247ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391247ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391247ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391248ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391248ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391248ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391248ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391248ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391248ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391248ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391248ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391248ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391248ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391249ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391249ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391249ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391249ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391249ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391249ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391249ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391249ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391249ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391249ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391250ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391250ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391250ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391250ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391250ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391250ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391250ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391251ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391251ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391251ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391251ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391251ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391251ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391251ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391251ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391251ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391251ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391252ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391252ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391252ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391252ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391252ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391252ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391252ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391252ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391252ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391252ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391252ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391252ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391252ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391254ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391254ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391254ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391254ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391254ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391254ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391254ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391254ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391254ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391254ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391254ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391254ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391254ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391255ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391255ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391255ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391255ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391255ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391255ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391255ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391255ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391255ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391255ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391256ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391256ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391256ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391256ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391256ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391256ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391256ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391256ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391256ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391256ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391257ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391257ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391257ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391257ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391257ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391257ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391257ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391257ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391257ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391257ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391257ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391257ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391257ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391258ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391258ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391258ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391258ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391258ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391258ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391258ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391258ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391258ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391258ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391258ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391258ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391258ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391259ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391259ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391259ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391259ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391259ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391259ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391259ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391259ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391259ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391259ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391260ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391260ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391260ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391260ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391260ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391260ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391260ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391260ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391260ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391260ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391260ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391260ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391260ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391261ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391261ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391261ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391261ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391261ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391261ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391261ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391261ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391261ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391261ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391262ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391262ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391262ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391262ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391262ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391262ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391262ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391262ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391262ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391262ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1139 11391263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391263ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391263ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391263ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1139 11391263ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1139 11391263ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1139 11391263ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1139 11391263ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401324ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401324ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401324ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401324ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401324ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401324ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401324ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401325ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401325ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401325ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401325ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401325ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401325ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401325ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401326ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401326ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401326ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401326ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401326ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401326ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401326ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401326ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401326ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401326ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401327ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401327ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401327ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401327ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401327ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401327ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401327ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401327ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401327ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401327ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401327ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401327ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401327ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401328ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401328ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401328ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401328ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401328ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401328ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401328ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401328ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401328ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401328ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401329ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401329ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401329ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401329ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401329ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401329ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401329ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401329ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401329ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401329ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401330ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401330ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401330ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401330ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401330ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401330ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401330ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401330ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401330ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401330ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401330ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401330ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401330ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401331ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401331ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401331ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401331ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401331ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401331ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401331ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401331ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401331ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401331ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401332ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401332ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401332ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401332ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401332ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401332ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401332ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401332ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401332ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401332ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401333ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401333ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401333ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401333ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401333ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401333ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401333ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401333ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401333ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401333ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401333ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401333ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401333ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401334ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401334ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401334ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401334ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401334ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401334ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401334ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401334ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401334ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401334ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401334ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401334ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401334ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401335ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401335ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401335ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401335ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401335ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401335ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401335ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401335ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401335ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401335ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401335ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401335ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401335ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401336ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401336ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401336ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401336ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401336ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401336ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401336ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401336ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401336ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401336ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401337ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401337ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401337ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401337ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401337ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401337ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401337ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401337ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401337ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401337ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401338ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401338ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401338ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401338ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401338ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401338ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401338ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401338ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401338ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401338ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401338ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401338ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401338ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401340ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401340ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401340ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401340ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401340ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401340ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401340ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401340ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401340ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401340ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401340ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401340ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401340ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401343ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401343ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401343ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401343ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401343ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401343ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401343ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401343ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401343ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401343ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401344ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401344ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401344ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401344ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401344ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401344ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401344ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401344ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401344ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401344ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401345ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401345ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401345ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401345ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401345ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401345ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401345ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401345ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401345ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401345ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401345ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401345ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401345ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401347ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401347ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401347ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401347ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401347ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401347ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401347ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401347ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401347ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401347ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401347ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401347ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401347ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401348ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401348ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401348ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401348ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401348ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401348ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401348ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401348ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401348ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401348ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401348ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401348ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401348ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401349ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401349ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401349ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401349ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401349ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401349ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401349ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401349ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401349ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401349ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401350ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401350ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401350ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401350ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401350ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401350ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401350ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401350ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401350ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401350ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401351ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401351ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401351ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401351ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401351ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401351ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401351ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401351ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401351ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401351ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401351ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401351ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401351ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401352ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401352ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401352ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401352ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401352ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401352ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401352ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401352ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401352ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401352ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401353ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401353ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401353ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401353ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401353ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401353ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401353ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401353ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401353ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401353ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401353ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401353ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401353ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401354ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401354ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401354ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401354ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401354ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401354ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401354ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401354ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401354ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401354ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401356ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401356ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401356ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401356ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401356ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401356ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401356ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401356ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401356ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401356ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401356ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401356ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401356ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401357ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401357ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401357ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401357ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401357ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401357ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401357ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401357ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401357ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401357ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401358ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401358ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401358ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401358ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401358ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401358ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401358ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401358ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401358ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401358ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401359ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401359ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401359ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401359ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401359ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401359ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401359ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401359ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401359ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401359ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401361ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401361ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401361ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401361ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401361ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401361ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401361ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401361ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401361ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401361ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401362ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401362ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401362ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401362ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401362ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401362ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401362ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401362ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401362ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401362ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401362ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401362ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401362ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401363ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401363ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401363ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401363ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401363ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401363ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401363ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401363ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401363ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401363ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401363ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401363ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401363ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401364ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401364ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401364ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401364ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401364ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401364ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401364ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401364ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401364ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401364ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401364ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401364ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401364ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401365ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401365ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401365ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401365ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401365ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401365ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401365ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401365ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401365ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401365ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401366ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401366ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401366ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401366ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401366ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401366ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401366ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401366ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401366ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401366ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401366ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401366ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401366ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401367ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401367ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401367ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401367ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401367ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401367ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401367ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401367ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401367ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401367ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401369ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401369ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401369ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401369ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401369ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401369ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401369ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401369ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401369ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401369ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401369ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401369ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401369ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401370ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401370ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401370ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401370ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401370ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401370ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401370ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401370ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401370ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401370ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401371ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401371ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401371ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401371ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401371ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401371ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401371ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401371ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401371ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401371ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401372ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401372ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401372ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401372ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401372ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401372ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401372ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401372ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401372ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401372ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401372ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401372ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401372ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401373ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401373ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401373ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401373ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401373ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401373ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401373ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401373ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401373ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401373ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401374ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401374ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401374ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401374ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401374ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401374ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401374ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401374ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401374ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401374ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401374ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401374ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401374ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401375ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401375ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401375ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401375ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401375ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401375ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401375ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401375ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401375ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401375ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401375ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401375ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401375ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401376ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401376ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401376ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401376ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401376ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401376ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401376ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401376ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401376ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401376ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401377ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401377ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401377ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401377ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401377ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401377ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401377ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401377ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401377ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401377ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401377ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401377ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401377ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401378ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401378ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401378ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401378ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401378ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401378ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401378ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401378ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401378ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401378ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401379ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401379ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401379ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401379ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401379ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401379ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401379ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401379ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401379ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401379ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401379ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401379ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401379ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401380ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401380ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401380ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401380ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401380ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401380ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401380ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401380ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401380ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401380ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401381ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401381ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401381ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401381ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401381ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401381ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401381ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401381ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401381ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401381ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401382ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401382ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401382ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401382ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401382ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401382ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401382ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401382ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401382ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401382ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401383ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401383ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401383ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401383ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401383ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401383ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401383ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401383ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401383ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401383ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401383ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401383ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401383ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401384ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401384ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401384ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401384ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401384ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401384ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401384ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401384ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401384ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401384ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401384ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401384ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401384ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401385ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401385ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401385ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401385ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401385ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401385ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401385ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401385ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401385ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401385ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401386ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401386ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401386ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401386ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401386ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401386ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401386ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401386ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401386ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401386ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401387ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401387ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401387ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401387ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401387ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401387ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401387ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401387ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401387ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401387ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401387ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401387ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401387ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401388ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401388ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401388ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401388ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401388ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401388ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401388ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401388ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401388ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401388ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401388ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401388ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401388ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401389ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401389ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401389ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401389ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401389ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401389ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401389ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401389ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401389ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401389ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401389ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401389ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401389ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401390ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401390ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401390ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401390ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401390ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401390ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401390ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401390ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401390ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401390ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401391ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401391ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401391ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401391ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401391ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401391ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401391ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401391ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401391ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401391ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401392ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401392ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401392ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401392ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401392ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401392ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401392ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401392ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401392ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401392ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401392ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401392ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401392ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401393ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401393ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401393ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401393ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401393ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401393ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401393ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401393ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401393ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401393ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401394ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401394ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401394ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401394ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401394ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401394ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401394ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401394ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401394ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401394ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401395ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401395ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401395ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401395ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401395ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401395ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401395ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401395ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401395ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401395ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401395ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401395ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401395ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401396ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401396ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401396ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401396ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401396ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401396ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401396ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401396ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401396ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401396ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401396ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401396ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401396ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401397ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401397ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401397ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401397ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401397ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401397ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401397ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401397ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401397ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401397ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401397ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401397ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401397ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401398ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401398ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401398ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401398ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401398ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401398ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401398ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401398ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401398ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401398ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401399ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401399ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401399ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401399ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401399ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401399ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401399ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401399ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401399ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401399ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401400ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401400ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401400ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401400ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401400ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401400ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401400ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401400ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401400ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401400ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401400ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401400ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401400ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401401ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401401ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401401ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401401ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401401ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401401ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401401ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401401ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401401ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401401ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401402ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401402ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401402ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401402ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401402ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401402ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401402ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401402ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401402ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401402ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401402ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401402ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401402ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401403ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401403ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401403ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401403ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401403ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1140 11401403ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401403ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401403ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401403ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1140 11401403ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1140 11401403ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1140 11401403ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1140 11401403ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421318ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421318ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421318ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421318ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421318ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421318ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421318ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421318ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421318ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421318ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421319ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421319ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421319ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421319ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421319ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421319ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421319ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421319ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421319ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421319ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421321ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421321ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421321ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421321ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421321ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421321ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421321ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421321ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421321ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421321ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421323ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421323ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421323ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421323ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421323ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421323ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421323ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421325ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421325ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421325ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421325ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421325ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421325ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421325ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421326ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421326ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421326ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421326ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421326ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421326ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421326ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421326ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421326ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421326ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421326ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421326ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421326ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421327ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421327ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421327ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421327ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421327ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421327ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421327ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421327ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421327ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421327ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421329ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421329ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421329ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421329ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421329ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421329ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421329ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421329ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421329ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421329ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421329ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421329ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421329ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421330ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421330ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421330ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421330ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421330ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421330ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421330ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421330ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421330ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421330ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421333ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421333ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421333ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421333ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421333ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421333ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421333ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421333ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421333ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421333ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421335ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421335ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421335ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421335ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421335ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421335ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421335ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421335ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421335ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421335ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421335ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421335ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421335ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421340ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421340ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421340ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421340ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421340ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421340ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421340ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421340ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421340ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421340ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421341ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421341ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421341ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421341ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421341ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421341ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421341ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421341ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421341ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421341ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421342ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421342ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421342ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421342ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421342ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421342ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421342ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421342ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421342ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421342ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421342ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421342ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421342ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421343ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421343ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421343ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421343ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421343ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421343ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421343ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421343ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421343ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421343ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421344ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421344ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421344ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421344ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421344ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421344ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421344ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421344ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421344ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421344ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421344ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421344ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421344ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421344ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421344ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421345ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421345ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421345ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421345ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421345ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421345ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421345ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421345ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421345ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421345ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421345ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421345ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421345ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421345ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421345ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421346ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421346ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421346ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421346ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421346ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421346ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421346ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421346ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421346ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421346ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421348ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421348ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421348ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421348ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421348ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421348ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421348ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421348ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421348ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421348ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421349ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421349ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421349ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421349ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421349ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421349ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421349ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421349ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421349ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421349ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421349ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421349ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421349ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421350ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421350ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421350ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421350ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421350ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421350ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421350ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421350ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421350ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421350ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421351ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421351ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421351ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421351ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421351ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421351ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421351ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421351ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421351ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421351ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421351ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421351ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421351ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421352ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421352ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421352ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421352ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421352ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421352ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421352ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421352ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421352ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421352ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421352ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421352ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421352ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421352ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421352ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421353ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421353ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421353ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421353ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421353ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421353ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421353ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421353ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421353ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421353ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421354ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421354ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421354ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421354ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421354ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421354ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421354ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421354ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421354ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421354ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421355ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421355ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421355ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421355ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421355ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421355ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421355ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421355ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421355ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421355ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421355ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421355ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421355ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421356ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421356ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421356ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421356ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421356ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421356ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421356ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421356ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421356ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421356ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421356ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421356ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421356ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421358ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421358ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421358ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421358ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421358ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421358ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421358ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421358ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421358ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421358ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421359ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421359ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421359ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421359ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421359ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421359ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421359ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421359ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421359ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421359ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421359ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421359ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421359ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421360ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421360ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421360ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421360ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421360ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421360ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421360ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421360ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421360ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421360ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421361ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421361ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421361ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421361ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421361ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421361ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421361ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421361ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421361ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421361ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421361ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421361ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421361ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421362ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421362ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421362ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421362ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421362ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421362ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421362ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421362ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421362ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421362ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421363ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421363ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421363ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421363ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421363ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421363ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421363ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421363ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421363ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421363ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421364ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421364ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421364ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421364ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421364ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421364ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421364ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421364ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421364ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421364ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421365ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421365ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421365ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421365ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421365ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421365ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421365ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421365ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421365ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421365ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421365ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421365ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421365ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421366ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421366ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421366ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421366ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421366ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421366ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421366ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421366ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421366ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421366ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421366ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421366ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421366ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421367ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421367ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421367ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421367ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421367ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421367ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421367ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421367ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421367ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421367ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421368ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421368ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421368ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421368ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421368ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421368ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421368ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421368ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421368ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421368ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421368ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421368ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421368ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421369ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421369ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421369ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421369ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421369ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421369ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421369ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421369ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421369ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421369ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421370ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421370ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421370ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421370ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421370ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421370ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421370ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421370ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421370ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421370ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421370ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421370ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421370ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421371ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421371ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421371ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421371ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421371ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421371ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421371ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421371ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421371ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421371ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421372ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421372ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421372ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421372ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421372ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421372ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421372ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421372ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421372ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421372ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421373ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421373ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421373ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421373ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421373ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421373ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421373ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421373ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421373ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421373ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421373ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421373ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421373ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421374ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421374ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421374ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421374ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421374ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421374ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421374ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421374ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421374ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421374ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421375ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421375ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421375ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421375ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421375ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421375ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421375ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421375ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421375ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421375ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421375ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421375ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421375ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421376ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421376ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421376ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421376ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421376ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421376ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421376ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421376ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421376ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421376ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421377ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421377ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421377ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421377ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421377ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421377ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421377ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421377ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421377ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421377ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421377ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421377ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421377ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421379ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421379ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421379ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421379ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421379ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421379ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421379ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421379ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421379ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421379ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421379ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421379ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421379ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421380ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421380ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421380ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421380ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421380ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421380ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421380ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421380ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421380ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421380ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421380ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421380ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421380ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421383ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421383ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421383ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421383ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421383ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421383ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421383ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421383ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421383ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421383ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421384ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421384ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421384ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421384ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421384ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421384ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421384ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421384ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421384ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421384ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421385ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421385ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421385ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421385ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421385ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421385ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421385ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421385ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421385ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421385ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421386ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421386ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421386ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421386ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421386ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421386ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421386ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421386ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421386ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421386ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421386ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421386ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421386ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421388ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421388ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421388ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421388ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421388ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421388ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421388ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421388ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421388ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421388ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421389ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421389ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421389ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421389ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421389ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421389ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421389ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421389ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421389ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421389ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421390ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421390ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421390ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421390ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421390ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421390ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421390ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421390ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421390ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421390ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421391ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421391ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421391ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421391ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421391ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421391ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421391ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421391ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421391ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421391ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421391ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421391ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421391ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421392ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421392ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421392ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421392ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421392ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421392ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421392ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421392ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421392ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421392ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421393ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421393ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421393ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421393ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421393ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421393ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421393ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421393ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421393ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421393ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421393ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421393ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421393ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421393ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421393ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421394ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421394ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421394ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421394ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421394ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421394ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421394ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421394ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421394ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421394ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421395ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421395ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421395ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421395ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421395ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421395ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421395ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421395ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421395ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421395ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421396ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421396ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421396ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421396ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421396ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1142 11421396ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421396ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421396ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421396ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1142 11421396ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1142 11421396ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1142 11421396ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1142 11421396ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471261ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471261ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471261ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471261ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471261ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1147 11471261ECSEQ1FDDTC Date of First Delay 2020-12-01 CRF C4591001ECC4591001 1147 11471261ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471261ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471261ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471261ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471261ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471262ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471262ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471262ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471262ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471262ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1147 11471262ECSEQ1FDDTC Date of First Delay 2020-12-01 CRF C4591001ECC4591001 1147 11471262ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471262ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471262ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471262ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471262ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471264ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471264ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471264ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471264ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471264ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471264ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471264ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471264ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471264ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471264ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471264ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471264ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471264ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471268ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471268ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471268ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471268ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471268ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471268ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471268ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471268ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471268ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471268ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471269ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471269ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471269ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471269ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471269ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471269ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471269ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471269ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471269ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471269ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471269ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471269ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471269ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471270ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471270ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471270ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471270ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471270ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471270ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471270ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471271ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471271ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471271ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471271ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471271ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471271ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471271ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471271ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471271ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471271ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471271ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471271ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471271ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471275ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471275ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471275ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471275ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471275ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471275ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471275ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471275ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471275ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471275ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471275ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471275ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471275ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471278ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471278ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471278ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471278ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471278ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471278ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471278ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471279ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471280ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1147 11471280ECSEQ1FDDTC Date of First Delay 2020-12-08 CRF C4591001ECC4591001 1147 11471280ECSEQ2ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471280ECSEQ2ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471280ECSEQ2ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471280ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471280ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471280ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471280ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471280ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471281ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471281ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471281ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471281ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471281ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471281ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471281ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471281ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471281ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471281ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471281ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471281ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471281ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471285ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471285ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471285ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471285ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471285ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471285ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471285ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471286ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471286ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471286ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471286ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471286ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471286ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471286ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471287ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471287ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471287ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471288ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471288ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471288ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471288ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471288ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471288ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471288ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471290ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471290ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471290ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471290ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471290ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471290ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471290ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471290ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471291ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471291ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471291ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471291ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471291ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471291ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471291ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471292ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471292ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471292ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471292ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471295ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471295ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471295ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471295ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471295ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471295ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471295ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471298ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471298ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471298ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471298ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471298ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471298ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471298ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471300ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471300ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471300ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471300ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471300ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471300ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471300ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471301ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471301ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471301ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471301ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471301ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471301ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471301ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471301ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471301ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471301ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471302ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471302ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471302ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471302ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471302ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471302ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471302ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471302ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471302ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471302ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471303ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471303ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471303ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471303ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471303ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471303ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471303ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471303ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471303ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471303ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471304ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471304ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471304ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471304ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471304ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471304ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471304ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471304ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471304ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471304ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471305ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471305ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471305ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471305ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471305ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471305ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471305ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471305ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471305ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471305ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471306ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471306ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471306ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471306ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471306ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471306ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471306ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471306ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471306ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471306ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471306ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471306ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471306ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471307ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471307ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471307ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471307ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471307ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471307ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471307ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471307ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471307ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471307ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471307ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471307ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471307ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471308ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471308ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471308ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471308ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471308ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471308ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471308ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471308ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471308ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471308ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471308ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471308ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471308ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471309ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471309ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471309ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471309ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471309ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471309ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471309ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471309ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471309ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471309ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471310ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471310ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471310ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471310ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471310ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471310ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471310ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471310ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471310ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471310ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471311ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471311ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471311ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471311ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471311ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471311ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471311ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471311ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471311ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471311ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471311ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471311ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471311ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471312ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471312ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471312ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471312ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471312ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471312ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471312ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471312ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471312ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471312ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471312ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471312ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471312ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471313ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471313ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471313ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471313ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471313ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471313ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471313ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471313ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471313ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471313ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471314ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471314ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471314ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471314ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471314ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471314ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471314ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471314ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471314ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471314ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471315ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471315ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471315ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471315ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471315ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471315ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471315ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471315ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471315ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471315ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471316ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471316ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471316ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471316ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471316ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471316ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471316ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471316ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471316ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471316ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471316ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471316ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471316ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471317ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471317ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471317ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471317ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471317ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471317ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471317ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471317ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471317ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471317ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471318ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471318ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471318ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471318ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471318ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471318ECSEQ2ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1147 11471318ECSEQ2FDDTC Date of First Delay 2021-01-23 CRF C4591001ECC4591001 1147 11471318ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471318ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471318ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471318ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471318ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471318ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471318ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471319ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471319ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471319ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471319ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471319ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471319ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471319ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471319ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471319ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471319ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471320ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471320ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471320ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471320ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471320ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471320ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471320ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471320ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471320ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471320ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471321ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471321ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471321ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471321ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471321ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471321ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471321ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471321ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471321ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471321ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471321ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471321ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471321ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471322ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471322ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471322ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471322ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471322ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471322ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471322ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471322ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471322ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471322ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471323ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471323ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471323ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471323ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471323ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471323ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471323ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471323ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471323ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471323ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471324ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471324ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471324ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471324ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471324ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471324ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471324ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471324ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471324ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471324ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471324ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471324ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1147 11471324ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471325ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471325ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471325ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471325ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471325ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471325ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471325ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1147 11471325ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1147 11471325ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1147 11471325ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1147 11471326ECSEQ1ECCD Standardized Medication Code